Protein,Protein_definition,Disease_category,Disease,NB_individual,NB_case,HR[95%CI],P_value
AGER,Advanced glycosylation end product-specific receptor,Chapter I Certain infectious and parasitic diseases,"Bacterial infection, other or unspecified",22497,177,1.22 [0.88-1.67],0.2312150831584373
AGER,Advanced glycosylation end product-specific receptor,Chapter I Certain infectious and parasitic diseases,"Bacterial intestinal infections, IBD co-morbidities",23519,188,1.45 [1.08-1.96],0.0147773794175124
AGER,Advanced glycosylation end product-specific receptor,Chapter I Certain infectious and parasitic diseases,"Bacterial, viral and other infectious agents",23277,1395,1.16 [1.03-1.29],0.0129895866479897
AGER,Advanced glycosylation end product-specific receptor,Chapter I Certain infectious and parasitic diseases,Candidiasis,23532,371,1.19 [0.96-1.48],0.1197143622117716
AGER,Advanced glycosylation end product-specific receptor,Chapter I Certain infectious and parasitic diseases,Certain infectious and parasitic diseases,22847,3445,1.13 [1.05-1.22],0.000865581669127
AGER,Advanced glycosylation end product-specific receptor,Chapter I Certain infectious and parasitic diseases,Condition for Implicit Sepsis (Organ dysfunction codes),22806,3467,1.16 [1.08-1.25],7.139064273261413e-05
AGER,Advanced glycosylation end product-specific receptor,Chapter I Certain infectious and parasitic diseases,Diarrhoea and gastroenteritis of presumed infectious origin,23320,1038,1.26 [1.10-1.43],0.0007354054683311
AGER,Advanced glycosylation end product-specific receptor,Chapter I Certain infectious and parasitic diseases,Enterocolitis due to Clostridium difficile,23456,81,1.91 [1.23-2.99],0.0043155810024408
AGER,Advanced glycosylation end product-specific receptor,Chapter I Certain infectious and parasitic diseases,Explicit Sepsis,21327,1109,1.23 [1.08-1.40],0.001676248243324
AGER,Advanced glycosylation end product-specific receptor,Chapter I Certain infectious and parasitic diseases,Implicit bacterial Sepsis,20578,1228,1.33 [1.18-1.50],5.4483479424660575e-06
AGER,Advanced glycosylation end product-specific receptor,Chapter I Certain infectious and parasitic diseases,Implicit fungal Sepsis,20304,249,1.30 [0.99-1.72],0.0590268710940888
AGER,Advanced glycosylation end product-specific receptor,Chapter I Certain infectious and parasitic diseases,Implicit Sepsis,16535,2253,1.08 [0.98-1.18],0.1060329188375912
AGER,Advanced glycosylation end product-specific receptor,Chapter I Certain infectious and parasitic diseases,Implicit viral Sepsis,20227,399,1.57 [1.27-1.95],2.987803598396e-05
AGER,Advanced glycosylation end product-specific receptor,Chapter I Certain infectious and parasitic diseases,Intestinal infectious diseases,23522,1240,1.25 [1.11-1.41],0.0003023377198241
AGER,Advanced glycosylation end product-specific receptor,Chapter I Certain infectious and parasitic diseases,Mycoses,23623,462,1.13 [0.93-1.38],0.2061505872345791
AGER,Advanced glycosylation end product-specific receptor,Chapter I Certain infectious and parasitic diseases,Other bacterial agents as the cause of diseases classified to other chapters,22768,886,1.15 [1.00-1.33],0.0579942360154005
AGER,Advanced glycosylation end product-specific receptor,Chapter I Certain infectious and parasitic diseases,Other bacterial diseases,23546,1226,1.21 [1.07-1.36],0.0025237421048711
AGER,Advanced glycosylation end product-specific receptor,Chapter I Certain infectious and parasitic diseases,Other bacterial intestinal infections,22472,190,1.45 [1.07-1.97],0.0157132347673087
AGER,Advanced glycosylation end product-specific receptor,Chapter I Certain infectious and parasitic diseases,Other infectious diseases,23662,51,1.42 [0.79-2.57],0.2406314838387409
AGER,Advanced glycosylation end product-specific receptor,Chapter I Certain infectious and parasitic diseases,Other septicaemia,23388,1068,1.20 [1.05-1.36],0.0065046381509971
AGER,Advanced glycosylation end product-specific receptor,Chapter I Certain infectious and parasitic diseases,Other specified/unspecified bacterial intestinal infections,23446,71,1.12 [0.68-1.84],0.6439748909273982
AGER,Advanced glycosylation end product-specific receptor,Chapter I Certain infectious and parasitic diseases,Other viral diseases,23602,123,1.47 [1.01-2.15],0.0455055158839151
AGER,Advanced glycosylation end product-specific receptor,Chapter I Certain infectious and parasitic diseases,"Other viral diseases, not elsewhere classified",23582,103,1.60 [1.06-2.41],0.0259999762374349
AGER,Advanced glycosylation end product-specific receptor,Chapter I Certain infectious and parasitic diseases,Streptococcus and staphylococcus as the cause of diseases classified to other chapters,22364,482,1.29 [1.06-1.57],0.0104125859402911
AGER,Advanced glycosylation end product-specific receptor,Chapter I Certain infectious and parasitic diseases,Viral agents as the cause of diseases classified to other chapters,22164,282,1.40 [1.09-1.80],0.0092648992783304
AGER,Advanced glycosylation end product-specific receptor,Chapter I Certain infectious and parasitic diseases,Viral and other specified intestinal infections,22370,88,1.39 [0.89-2.18],0.1499117720416032
AGER,Advanced glycosylation end product-specific receptor,Chapter I Certain infectious and parasitic diseases,Viral hepatitis,23643,70,1.34 [0.82-2.21],0.2418463973047346
AGER,Advanced glycosylation end product-specific receptor,Chapter I Certain infectious and parasitic diseases,Viral infections characterized by skin and mucous membrane lesions,23606,143,1.05 [0.73-1.51],0.7914391206594789
AGER,Advanced glycosylation end product-specific receptor,Chapter I Certain infectious and parasitic diseases,Viral warts,23514,51,1.31 [0.72-2.38],0.3758817094218353
AGER,Advanced glycosylation end product-specific receptor,Chapter I Certain infectious and parasitic diseases,Zoster [herpes zoster],23514,51,1.03 [0.57-1.88],0.9135304472190078
AGER,Advanced glycosylation end product-specific receptor,Chapter II Neoplasms,Benign lipomatous neoplasm,23348,336,0.91 [0.72-1.16],0.4459857836518049
AGER,Advanced glycosylation end product-specific receptor,Chapter II Neoplasms,Benign lipomatous neoplasm of skin and subcutaneous tissue of limbs,23591,45,0.64 [0.33-1.23],0.1790051241320893
AGER,Advanced glycosylation end product-specific receptor,Chapter II Neoplasms,Benign lipomatous neoplasm of skin and subcutaneous tissue of trunk,23558,51,0.95 [0.51-1.76],0.8697573042111844
AGER,Advanced glycosylation end product-specific receptor,Chapter II Neoplasms,Benign lipomatous neoplasm of spermatic cord,23613,125,0.81 [0.55-1.20],0.2889207251594672
AGER,Advanced glycosylation end product-specific receptor,Chapter II Neoplasms,"Benign neoplasm of colon, rectum, anus and anal canal",23290,1634,1.00 [0.90-1.11],0.9974380790879622
AGER,Advanced glycosylation end product-specific receptor,Chapter II Neoplasms,Benign neoplasm of meninges,23662,33,0.65 [0.31-1.40],0.2735732233342163
AGER,Advanced glycosylation end product-specific receptor,Chapter II Neoplasms,Benign neoplasm of other and ill-defined parts of digestive system,23599,64,2.12 [1.30-3.47],0.0026590906894888
AGER,Advanced glycosylation end product-specific receptor,Chapter II Neoplasms,Benign neoplasm of other and unspecified endocrine glands,23647,78,2.12 [1.36-3.30],0.0008533540510102
AGER,Advanced glycosylation end product-specific receptor,Chapter II Neoplasms,Benign neoplasm: Ascending colon,23637,438,1.01 [0.82-1.24],0.93075519629176
AGER,Advanced glycosylation end product-specific receptor,Chapter II Neoplasms,Benign neoplasm: Caecum,23632,337,0.80 [0.63-1.01],0.0627261710149931
AGER,Advanced glycosylation end product-specific receptor,Chapter II Neoplasms,"Benign neoplasm: Colon, unspecified",23534,81,1.02 [0.63-1.63],0.945074034512139
AGER,Advanced glycosylation end product-specific receptor,Chapter II Neoplasms,Benign neoplasm: Descending colon,23629,273,0.67 [0.52-0.88],0.0034709728787327
AGER,Advanced glycosylation end product-specific receptor,Chapter II Neoplasms,Benign neoplasm: Rectum,23590,416,0.94 [0.76-1.16],0.5679417650262435
AGER,Advanced glycosylation end product-specific receptor,Chapter II Neoplasms,Benign neoplasm: Sigmoid colon,23537,728,0.99 [0.85-1.17],0.9402117276407164
AGER,Advanced glycosylation end product-specific receptor,Chapter II Neoplasms,Benign neoplasm: Transverse colon,23619,556,0.89 [0.74-1.06],0.1992128003816228
AGER,Advanced glycosylation end product-specific receptor,Chapter II Neoplasms,"Chronic lymphocytic leukaemia and small lyphocytis leukaemia, excluding all cancers (controls excluding all cancers)",18372,70,0.77 [0.45-1.30],0.3201756343766858
AGER,Advanced glycosylation end product-specific receptor,Chapter II Neoplasms,"Diffuse large B-cell lymphoma, excluding all cancers (controls excluding all cancers)",18372,70,1.31 [0.78-2.19],0.3046281656326393
AGER,Advanced glycosylation end product-specific receptor,Chapter II Neoplasms,"Haemangioma and lymphangioma, any site",23631,100,1.32 [0.86-2.02],0.202463446085215
AGER,Advanced glycosylation end product-specific receptor,Chapter II Neoplasms,"Haemangioma, any site",23631,98,1.37 [0.90-2.11],0.1454349407168373
AGER,Advanced glycosylation end product-specific receptor,Chapter II Neoplasms,Lung cancer and mesothelioma,15738,338,0.61 [0.48-0.78],5.548113259127363e-05
AGER,Advanced glycosylation end product-specific receptor,Chapter II Neoplasms,Lymphoid leukaemia,18367,65,0.88 [0.51-1.51],0.6421747744790767
AGER,Advanced glycosylation end product-specific receptor,Chapter II Neoplasms,"Malignant melanoma of skin, excluding all cancers (controls excluding all cancers)",18499,197,0.93 [0.68-1.28],0.6514678987252527
AGER,Advanced glycosylation end product-specific receptor,Chapter II Neoplasms,"Malignant neoplasm of bladder, excluding all cancers (controls excluding all cancers)",18589,287,1.04 [0.80-1.34],0.7780789232602334
AGER,Advanced glycosylation end product-specific receptor,Chapter II Neoplasms,"Malignant neoplasm of intrahepatic ducts, biliary tract and gallbladder, excluding all cancers (controls excluding all cancers)",18396,94,0.97 [0.62-1.51],0.8841909192098891
AGER,Advanced glycosylation end product-specific receptor,Chapter II Neoplasms,"Malignant neoplasm of kidney, except renal pelvis, excluding all cancers (controls excluding all cancers)",18445,143,1.38 [0.97-1.97],0.0729385939059266
AGER,Advanced glycosylation end product-specific receptor,Chapter II Neoplasms,"Malignant neoplasm of oesophagus, excluding all cancers (controls excluding all cancers)",18440,138,1.13 [0.78-1.63],0.5201806206473445
AGER,Advanced glycosylation end product-specific receptor,Chapter II Neoplasms,"Malignant neoplasm of pancreas, excluding all cancers (controls excluding all cancers)",18385,83,0.80 [0.49-1.28],0.3507928084670229
AGER,Advanced glycosylation end product-specific receptor,Chapter II Neoplasms,"Malignant neoplasm of prostate, excluding all cancers (controls excluding all cancers)",19691,1389,0.93 [0.83-1.05],0.224556829244731
AGER,Advanced glycosylation end product-specific receptor,Chapter II Neoplasms,"Malignant neoplasm of rectum, excluding all cancers (controls excluding all cancers)",18443,141,0.77 [0.53-1.12],0.1787346399666537
AGER,Advanced glycosylation end product-specific receptor,Chapter II Neoplasms,"Malignant neoplasm of stomach, excluding all cancers (controls excluding all cancers)",18408,106,0.85 [0.56-1.29],0.4470556192934558
AGER,Advanced glycosylation end product-specific receptor,Chapter II Neoplasms,Malignant neoplasms of independent (primary) multiple sites,18432,130,1.27 [0.87-1.87],0.2187987113310706
AGER,Advanced glycosylation end product-specific receptor,Chapter II Neoplasms,Melanocytic naevi,23534,168,1.09 [0.78-1.53],0.6029548259652211
AGER,Advanced glycosylation end product-specific receptor,Chapter II Neoplasms,Melanocytic naevi of trunk,23630,94,0.93 [0.59-1.46],0.7555726946913915
AGER,Advanced glycosylation end product-specific receptor,Chapter II Neoplasms,Melanoma in situ,18335,73,1.10 [0.66-1.84],0.7208005243278646
AGER,Advanced glycosylation end product-specific receptor,Chapter II Neoplasms,"Non-follicular lymphoma, hilmo, excluding all cancers",18401,99,1.08 [0.70-1.67],0.7304241171258572
AGER,Advanced glycosylation end product-specific receptor,Chapter II Neoplasms,"Non-Hodgkin lymphoma, all, excluding all cancers (controls excluding all cancers)",18468,166,1.03 [0.74-1.45],0.8553450301563925
AGER,Advanced glycosylation end product-specific receptor,Chapter II Neoplasms,"Non-small cell lung cancer, excluding all cancers (controls excluding all cancers)",18515,213,0.61 [0.46-0.82],0.0010477720446856
AGER,Advanced glycosylation end product-specific receptor,Chapter II Neoplasms,"Other and unspecified types of non-Hodgkin lymphoma, hilmo, excluding all cancers",18404,102,1.04 [0.67-1.59],0.8727096948156063
AGER,Advanced glycosylation end product-specific receptor,Chapter II Neoplasms,Other benign neoplasms of skin,23531,140,0.80 [0.55-1.16],0.2373342474461082
AGER,Advanced glycosylation end product-specific receptor,Chapter II Neoplasms,"Other malignant neoplasms of skin (=non-melanoma skin cancer), excluding all cancers (controls excluding all cancers)",19505,1203,1.06 [0.94-1.21],0.3501791132551674
AGER,Advanced glycosylation end product-specific receptor,Chapter II Neoplasms,"Squamous cell neoplasms and carcinomas of the skin, excluding all cancers (controls excluding all cancers)",19583,1281,1.07 [0.95-1.21],0.2694395525115292
AGER,Advanced glycosylation end product-specific receptor,Chapter III Diseases of the blood and blood-forming organs and certain disorders involving the immune mechanism,Agranulocytosis,23387,306,0.96 [0.75-1.22],0.7298506656608559
AGER,Advanced glycosylation end product-specific receptor,Chapter III Diseases of the blood and blood-forming organs and certain disorders involving the immune mechanism,Anaemia in chronic diseases classified elsewhere,21930,118,3.84 [2.93-5.03],2.4059495848153937e-22
AGER,Advanced glycosylation end product-specific receptor,Chapter III Diseases of the blood and blood-forming organs and certain disorders involving the immune mechanism,Diseases of spleen,23154,73,1.02 [0.62-1.69],0.9372308270852718
AGER,Advanced glycosylation end product-specific receptor,Chapter III Diseases of the blood and blood-forming organs and certain disorders involving the immune mechanism,Diseases of the blood and blood-forming organs and certain disorders involving the immune mechanism,23101,2773,1.20 [1.10-1.30],1.666732197445027e-05
AGER,Advanced glycosylation end product-specific receptor,Chapter III Diseases of the blood and blood-forming organs and certain disorders involving the immune mechanism,Folate deficiency anaemia,22384,59,1.73 [1.01-2.94],0.044624209265387
AGER,Advanced glycosylation end product-specific receptor,Chapter III Diseases of the blood and blood-forming organs and certain disorders involving the immune mechanism,Idiopathic thrombocytopenic purpura,23240,53,1.14 [0.63-2.04],0.6689553770349449
AGER,Advanced glycosylation end product-specific receptor,Chapter III Diseases of the blood and blood-forming organs and certain disorders involving the immune mechanism,Other anaemias,23282,1470,1.35 [1.21-1.51],8.057099903131896e-08
AGER,Advanced glycosylation end product-specific receptor,Chapter III Diseases of the blood and blood-forming organs and certain disorders involving the immune mechanism,Other and unspecified anaemias,23280,1468,1.35 [1.21-1.51],7.119421313277395e-08
AGER,Advanced glycosylation end product-specific receptor,Chapter III Diseases of the blood and blood-forming organs and certain disorders involving the immune mechanism,Other and unspecified aplastic anaemias,21916,104,1.33 [0.87-2.01],0.1857772822725757
AGER,Advanced glycosylation end product-specific receptor,Chapter III Diseases of the blood and blood-forming organs and certain disorders involving the immune mechanism,Other and unspecified iron deficiency,23424,1099,1.37 [1.20-1.55],1.2561200643549291e-06
AGER,Advanced glycosylation end product-specific receptor,Chapter III Diseases of the blood and blood-forming organs and certain disorders involving the immune mechanism,Other coagulation defects,23291,104,1.68 [1.12-2.52],0.0128043334212408
AGER,Advanced glycosylation end product-specific receptor,Chapter III Diseases of the blood and blood-forming organs and certain disorders involving the immune mechanism,Other diseases of blood and blood-forming organs,23157,76,0.74 [0.45-1.21],0.2274518619765595
AGER,Advanced glycosylation end product-specific receptor,Chapter III Diseases of the blood and blood-forming organs and certain disorders involving the immune mechanism,Other disorders of white blood cells,23142,61,1.34 [0.78-2.31],0.2869557934455907
AGER,Advanced glycosylation end product-specific receptor,Chapter III Diseases of the blood and blood-forming organs and certain disorders involving the immune mechanism,Purpura and other haemorrhagic conditions,23499,312,1.30 [1.02-1.65],0.032089981922841
AGER,Advanced glycosylation end product-specific receptor,Chapter III Diseases of the blood and blood-forming organs and certain disorders involving the immune mechanism,Sarcoidosis,23564,49,0.66 [0.35-1.23],0.1941231388495184
AGER,Advanced glycosylation end product-specific receptor,Chapter III Diseases of the blood and blood-forming organs and certain disorders involving the immune mechanism,"Thrombocytopenia, unspecified",23441,254,1.34 [1.03-1.74],0.0299304582139867
AGER,Advanced glycosylation end product-specific receptor,Chapter III Diseases of the blood and blood-forming organs and certain disorders involving the immune mechanism,Vitamin B12 deficiency anaemia,22403,78,1.94 [1.24-3.04],0.0037943966504751
AGER,Advanced glycosylation end product-specific receptor,"Chapter IV Endocrine, nutritional and metabolic diseases",Acidosis,17435,373,1.34 [1.07-1.67],0.0106796944196619
AGER,Advanced glycosylation end product-specific receptor,"Chapter IV Endocrine, nutritional and metabolic diseases",Acute alcohol intoxication,21633,162,0.47 [0.33-0.66],1.5919028774015856e-05
AGER,Advanced glycosylation end product-specific receptor,"Chapter IV Endocrine, nutritional and metabolic diseases",Alcohol dependence,21660,189,0.37 [0.27-0.50],3.43256547188809e-10
AGER,Advanced glycosylation end product-specific receptor,"Chapter IV Endocrine, nutritional and metabolic diseases",Alkalosis,17115,53,0.95 [0.52-1.75],0.8783835654228246
AGER,Advanced glycosylation end product-specific receptor,"Chapter IV Endocrine, nutritional and metabolic diseases",Bipolar affective disorders,22295,64,0.86 [0.50-1.47],0.5754736989744051
AGER,Advanced glycosylation end product-specific receptor,"Chapter IV Endocrine, nutritional and metabolic diseases",Deficiency of other B group vitamins,21527,222,1.18 [0.89-1.57],0.2492918965811284
AGER,Advanced glycosylation end product-specific receptor,"Chapter IV Endocrine, nutritional and metabolic diseases","Delirium, not induced by alcohol and other psychoactive substances",23163,613,0.99 [0.83-1.17],0.8982496298363601
AGER,Advanced glycosylation end product-specific receptor,"Chapter IV Endocrine, nutritional and metabolic diseases",Dementia in Alzheimer disease,22789,239,0.82 [0.62-1.08],0.1559754930464494
AGER,Advanced glycosylation end product-specific receptor,"Chapter IV Endocrine, nutritional and metabolic diseases",Dementia in other diseases classified elsewhere,22717,167,0.72 [0.52-1.01],0.0587841487676968
AGER,Advanced glycosylation end product-specific receptor,"Chapter IV Endocrine, nutritional and metabolic diseases",Depression,23361,1130,1.11 [0.98-1.26],0.1022612903180508
AGER,Advanced glycosylation end product-specific receptor,"Chapter IV Endocrine, nutritional and metabolic diseases",Depression or dysthymia,20245,1086,1.10 [0.97-1.26],0.140465171517926
AGER,Advanced glycosylation end product-specific receptor,"Chapter IV Endocrine, nutritional and metabolic diseases","Disorder of lipoprotein metabolism, unspecified",17137,75,1.23 [0.75-2.04],0.4101004416867947
AGER,Advanced glycosylation end product-specific receptor,"Chapter IV Endocrine, nutritional and metabolic diseases","Disorder of thyroid, unspecified",22793,39,1.39 [0.71-2.73],0.3334844173760571
AGER,Advanced glycosylation end product-specific receptor,"Chapter IV Endocrine, nutritional and metabolic diseases",Disorders of calcium metabolism,17332,270,1.37 [1.05-1.78],0.0206950063060088
AGER,Advanced glycosylation end product-specific receptor,"Chapter IV Endocrine, nutritional and metabolic diseases",Disorders of iron metabolism,17137,75,1.08 [0.64-1.81],0.7715412990587891
AGER,Advanced glycosylation end product-specific receptor,"Chapter IV Endocrine, nutritional and metabolic diseases",Disorders of lipoprotein metabolism and other lipidaemias,20912,3850,1.02 [0.95-1.10],0.503266861594951
AGER,Advanced glycosylation end product-specific receptor,"Chapter IV Endocrine, nutritional and metabolic diseases",Disorders of magnesium metabolism,17247,185,1.22 [0.89-1.68],0.2238864038858242
AGER,Advanced glycosylation end product-specific receptor,"Chapter IV Endocrine, nutritional and metabolic diseases",Disorders of mineral metabolism,17626,564,1.19 [0.99-1.43],0.0601425719021974
AGER,Advanced glycosylation end product-specific receptor,"Chapter IV Endocrine, nutritional and metabolic diseases",Disorders of other endocrine glands,23603,277,1.91 [1.50-2.43],1.579763591130337e-07
AGER,Advanced glycosylation end product-specific receptor,"Chapter IV Endocrine, nutritional and metabolic diseases",Disorders of parathyroid gland,23417,91,3.57 [2.61-4.88],1.889294512976749e-15
AGER,Advanced glycosylation end product-specific receptor,"Chapter IV Endocrine, nutritional and metabolic diseases",Disorders of phosphorus metabolism and phosphatases,17212,150,0.99 [0.69-1.43],0.9558747258097876
AGER,Advanced glycosylation end product-specific receptor,"Chapter IV Endocrine, nutritional and metabolic diseases","Disorders of plasma-protein metabolism, not elsewhere classified",17128,66,1.41 [0.83-2.38],0.2023619267022742
AGER,Advanced glycosylation end product-specific receptor,"Chapter IV Endocrine, nutritional and metabolic diseases",Disorders of the thyroid gland,23486,732,1.33 [1.14-1.55],0.0003718236691612
AGER,Advanced glycosylation end product-specific receptor,"Chapter IV Endocrine, nutritional and metabolic diseases",Fluid overload,17367,305,2.18 [1.74-2.73],1.6813617599698262e-11
AGER,Advanced glycosylation end product-specific receptor,"Chapter IV Endocrine, nutritional and metabolic diseases",Hyperkalaemia,17440,378,2.09 [1.70-2.58],3.107257985847364e-12
AGER,Advanced glycosylation end product-specific receptor,"Chapter IV Endocrine, nutritional and metabolic diseases","Hyperlipidaemia, other/unspecified",17786,724,1.01 [0.86-1.19],0.8651875232903715
AGER,Advanced glycosylation end product-specific receptor,"Chapter IV Endocrine, nutritional and metabolic diseases",Hyperosmolality and hypernatraemia,17206,144,1.01 [0.70-1.45],0.9620697705413022
AGER,Advanced glycosylation end product-specific receptor,"Chapter IV Endocrine, nutritional and metabolic diseases",Hyperparathyroidism,23410,84,3.90 [2.88-5.28],1.1017645216946357e-18
AGER,Advanced glycosylation end product-specific receptor,"Chapter IV Endocrine, nutritional and metabolic diseases",Hypo-osmolality and hyponatraemia,17634,572,1.20 [1.00-1.44],0.0534209589491744
AGER,Advanced glycosylation end product-specific receptor,"Chapter IV Endocrine, nutritional and metabolic diseases",Hypokalaemia,17448,386,0.90 [0.72-1.13],0.3799267954968097
AGER,Advanced glycosylation end product-specific receptor,"Chapter IV Endocrine, nutritional and metabolic diseases",Iron deficiency,21372,67,1.84 [1.11-3.06],0.0178675521272147
AGER,Advanced glycosylation end product-specific receptor,"Chapter IV Endocrine, nutritional and metabolic diseases",Metabolic disorders,22226,5164,1.03 [0.97-1.09],0.3281127088021818
AGER,Advanced glycosylation end product-specific receptor,"Chapter IV Endocrine, nutritional and metabolic diseases",Nontoxic multinodular goitre,22774,20,3.09 [1.51-6.34],0.0020569819112444
AGER,Advanced glycosylation end product-specific receptor,"Chapter IV Endocrine, nutritional and metabolic diseases",Nontoxic single thyroid nodule,22775,21,1.31 [0.53-3.28],0.5596825382115806
AGER,Advanced glycosylation end product-specific receptor,"Chapter IV Endocrine, nutritional and metabolic diseases",Obesity,23490,1769,0.93 [0.84-1.04],0.1986725228006054
AGER,Advanced glycosylation end product-specific receptor,"Chapter IV Endocrine, nutritional and metabolic diseases","Obesity, other/unspecified",23487,1765,0.93 [0.84-1.03],0.1675149372727558
AGER,Advanced glycosylation end product-specific receptor,"Chapter IV Endocrine, nutritional and metabolic diseases",Other and/or unspecified nontoxic goitre,22777,23,1.44 [0.62-3.37],0.3984849455851406
AGER,Advanced glycosylation end product-specific receptor,"Chapter IV Endocrine, nutritional and metabolic diseases",Other anxiety disorders,23391,789,1.07 [0.91-1.24],0.4160978264827737
AGER,Advanced glycosylation end product-specific receptor,"Chapter IV Endocrine, nutritional and metabolic diseases","Other disorders of fluid, electrolyte and acid-base balance",18675,1613,1.23 [1.11-1.37],0.000129221354309
AGER,Advanced glycosylation end product-specific receptor,"Chapter IV Endocrine, nutritional and metabolic diseases",Other disorders of glucose regulation and pancreatic internal secretion,23651,265,1.83 [1.44-2.34],1.1339525469569582e-06
AGER,Advanced glycosylation end product-specific receptor,"Chapter IV Endocrine, nutritional and metabolic diseases",Other mental disorders due to brain damage and dysfunction and to physical disease,22657,107,1.21 [0.81-1.82],0.3535526675927097
AGER,Advanced glycosylation end product-specific receptor,"Chapter IV Endocrine, nutritional and metabolic diseases",Panic disorder,22678,76,0.54 [0.33-0.89],0.0153739061660788
AGER,Advanced glycosylation end product-specific receptor,"Chapter IV Endocrine, nutritional and metabolic diseases",Phobic anxiety disorders,22683,81,1.23 [0.77-1.97],0.3811289952836395
AGER,Advanced glycosylation end product-specific receptor,"Chapter IV Endocrine, nutritional and metabolic diseases","Postprocedural endocrine and metabolic disorders, not elsewhere classified",17127,65,1.73 [1.01-2.94],0.0448308258296894
AGER,Advanced glycosylation end product-specific receptor,"Chapter IV Endocrine, nutritional and metabolic diseases",Type 1 diabetes without complications,20886,168,1.37 [1.00-1.87],0.0520082866887286
AGER,Advanced glycosylation end product-specific receptor,"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with neurological complications,2497,121,1.71 [1.19-2.46],0.0039933336574327
AGER,Advanced glycosylation end product-specific receptor,"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with ophthalmic complications,2659,316,1.05 [0.83-1.33],0.6704250178697578
AGER,Advanced glycosylation end product-specific receptor,"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with peripheral circulatory complications,20816,98,1.22 [0.80-1.87],0.3497067695982657
AGER,Advanced glycosylation end product-specific receptor,"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with renal complications,2455,81,4.65 [3.17-6.82],3.724230337260025e-15
AGER,Advanced glycosylation end product-specific receptor,"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes without complications,22873,2155,0.87 [0.79-0.95],0.0023736897409316
AGER,Advanced glycosylation end product-specific receptor,"Chapter IV Endocrine, nutritional and metabolic diseases",Unspecified dementia,22909,359,0.90 [0.72-1.12],0.3337272852290791
AGER,Advanced glycosylation end product-specific receptor,"Chapter IV Endocrine, nutritional and metabolic diseases",Vitamin D deficiency,21545,240,1.18 [0.90-1.55],0.2310930444055328
AGER,Advanced glycosylation end product-specific receptor,"Chapter IV Endocrine, nutritional and metabolic diseases",Volume depletion,17858,796,1.25 [1.07-1.45],0.0047787783178538
AGER,Advanced glycosylation end product-specific receptor,Chapter IX Diseases of the circulatory system,"!Phlebitis/thrombophlebitis venae iliacae [externae/internae/communis], drug-induced",23537,252,1.07 [0.82-1.41],0.6106641880936133
AGER,Advanced glycosylation end product-specific receptor,Chapter IX Diseases of the circulatory system,Abdominal aortic aneurysm (AAA),22432,270,1.02 [0.78-1.33],0.8774014926680016
AGER,Advanced glycosylation end product-specific receptor,Chapter IX Diseases of the circulatory system,Angina pectoris,20753,1482,1.07 [0.96-1.20],0.2178052615575514
AGER,Advanced glycosylation end product-specific receptor,Chapter IX Diseases of the circulatory system,Aortic aneurysm,22542,380,1.09 [0.87-1.36],0.4627662360820687
AGER,Advanced glycosylation end product-specific receptor,Chapter IX Diseases of the circulatory system,Arterial embolism and thrombosis of lower extremity artery,22245,83,1.37 [0.86-2.19],0.1851817275169948
AGER,Advanced glycosylation end product-specific receptor,Chapter IX Diseases of the circulatory system,"Atherosclerosis, excluding cerebral and coronary sclerosis",22410,248,1.57 [1.20-2.05],0.0010569990364577
AGER,Advanced glycosylation end product-specific receptor,Chapter IX Diseases of the circulatory system,Atrial fibrillation and flutter,13849,2302,1.11 [1.02-1.22],0.0210640871481084
AGER,Advanced glycosylation end product-specific receptor,Chapter IX Diseases of the circulatory system,AV-block,19024,620,1.33 [1.12-1.59],0.0012948745887618
AGER,Advanced glycosylation end product-specific receptor,Chapter IX Diseases of the circulatory system,"Bradycardia, unspecified, drug-induced",23586,530,1.40 [1.16-1.68],0.0003249061153897
AGER,Advanced glycosylation end product-specific receptor,Chapter IX Diseases of the circulatory system,Cardiac arrest,11794,247,1.50 [1.14-1.97],0.004234640142269
AGER,Advanced glycosylation end product-specific receptor,Chapter IX Diseases of the circulatory system,Cardiomyopathy,18605,201,1.42 [1.05-1.94],0.0241150231718125
AGER,Advanced glycosylation end product-specific receptor,Chapter IX Diseases of the circulatory system,"Cardiomyopathy, other and unspecified",18514,110,1.25 [0.82-1.89],0.3056800796030373
AGER,Advanced glycosylation end product-specific receptor,Chapter IX Diseases of the circulatory system,Cerebral atherosclerosis,23663,68,1.64 [1.01-2.67],0.0474368280150026
AGER,Advanced glycosylation end product-specific receptor,Chapter IX Diseases of the circulatory system,Conduction disorders,19767,1363,1.27 [1.13-1.43],6.152136583381185e-05
AGER,Advanced glycosylation end product-specific receptor,Chapter IX Diseases of the circulatory system,Coronary atherosclerosis,21854,2607,1.08 [0.99-1.17],0.0911309430482867
AGER,Advanced glycosylation end product-specific receptor,Chapter IX Diseases of the circulatory system,Death due to cardiac causes,19921,7713,0.90 [0.86-0.95],4.942389315124736e-05
AGER,Advanced glycosylation end product-specific receptor,Chapter IX Diseases of the circulatory system,DVT of lower extremities,22432,276,1.14 [0.88-1.48],0.3087756891431366
AGER,Advanced glycosylation end product-specific receptor,Chapter IX Diseases of the circulatory system,Endocarditis,18487,83,1.58 [0.98-2.54],0.0587288195792451
AGER,Advanced glycosylation end product-specific receptor,Chapter IX Diseases of the circulatory system,"Heart failure, strict",23353,1322,1.30 [1.16-1.46],1.0324233166874712e-05
AGER,Advanced glycosylation end product-specific receptor,Chapter IX Diseases of the circulatory system,Hypertension,21113,6723,0.89 [0.85-0.94],5.122679305606487e-05
AGER,Advanced glycosylation end product-specific receptor,Chapter IX Diseases of the circulatory system,"Hypertension, essential",21136,6746,0.90 [0.85-0.95],0.0001789158733524
AGER,Advanced glycosylation end product-specific receptor,Chapter IX Diseases of the circulatory system,"Hypertension, portal",23431,113,1.16 [0.78-1.72],0.4655650300947681
AGER,Advanced glycosylation end product-specific receptor,Chapter IX Diseases of the circulatory system,"Hypertension, Pulmonary Arterial",14573,183,2.31 [1.74-3.07],8.308169719887523e-09
AGER,Advanced glycosylation end product-specific receptor,Chapter IX Diseases of the circulatory system,Hypertensive Renal Disease,14559,169,5.33 [4.41-6.45],1.8225182374376812e-66
AGER,Advanced glycosylation end product-specific receptor,Chapter IX Diseases of the circulatory system,Hypotension,23516,1237,1.42 [1.26-1.60],6.6878814355464055e-09
AGER,Advanced glycosylation end product-specific receptor,Chapter IX Diseases of the circulatory system,Intracerebral haemorrhage,22597,119,1.17 [0.79-1.73],0.4227058625291353
AGER,Advanced glycosylation end product-specific receptor,Chapter IX Diseases of the circulatory system,"Ischaemic heart disease, wide definition",21999,2728,1.05 [0.96-1.14],0.276669363685129
AGER,Advanced glycosylation end product-specific receptor,Chapter IX Diseases of the circulatory system,"Ischaemic Stroke, excluding all haemorrhages",23234,650,1.05 [0.89-1.25],0.5359491076520986
AGER,Advanced glycosylation end product-specific receptor,Chapter IX Diseases of the circulatory system,Left bundle-branch block,18823,419,1.54 [1.25-1.90],4.232158421549243e-05
AGER,Advanced glycosylation end product-specific receptor,Chapter IX Diseases of the circulatory system,Major coronary heart disease event,22938,1054,1.10 [0.97-1.26],0.1524417669281887
AGER,Advanced glycosylation end product-specific receptor,Chapter IX Diseases of the circulatory system,"Myocardial infarction, strict",20187,916,1.15 [0.99-1.32],0.0587083186337607
AGER,Advanced glycosylation end product-specific receptor,Chapter IX Diseases of the circulatory system,"Myocardial infarction, with ST-elevation",23501,220,1.31 [0.99-1.74],0.0596103122625098
AGER,Advanced glycosylation end product-specific receptor,Chapter IX Diseases of the circulatory system,"Myocardial infarction, without ST-elevation",23611,369,1.00 [0.80-1.25],0.9966988614439172
AGER,Advanced glycosylation end product-specific receptor,Chapter IX Diseases of the circulatory system,Oesophageal varices,22228,72,1.28 [0.78-2.09],0.3319193424882128
AGER,Advanced glycosylation end product-specific receptor,Chapter IX Diseases of the circulatory system,Other aneurysm,22259,97,0.99 [0.64-1.54],0.9625795329714242
AGER,Advanced glycosylation end product-specific receptor,Chapter IX Diseases of the circulatory system,Other arrhythmias,18881,477,1.19 [0.97-1.45],0.0976150374883483
AGER,Advanced glycosylation end product-specific receptor,Chapter IX Diseases of the circulatory system,Other arterial embolism and thrombosis,22296,134,1.42 [0.98-2.06],0.0609400433617865
AGER,Advanced glycosylation end product-specific receptor,Chapter IX Diseases of the circulatory system,Other diseases of arteries and capillaries,22446,284,1.39 [1.08-1.79],0.0103741144993907
AGER,Advanced glycosylation end product-specific receptor,Chapter IX Diseases of the circulatory system,Other diseases of pericardium,18595,191,1.35 [0.99-1.85],0.06041781998338
AGER,Advanced glycosylation end product-specific receptor,Chapter IX Diseases of the circulatory system,Other disorders of veins,22254,98,1.29 [0.84-1.96],0.2413428411431629
AGER,Advanced glycosylation end product-specific receptor,Chapter IX Diseases of the circulatory system,Other embolism and thrombosis,22206,50,1.22 [0.67-2.22],0.5164927603262504
AGER,Advanced glycosylation end product-specific receptor,Chapter IX Diseases of the circulatory system,Other intracranial haemorrhages,22074,88,1.09 [0.69-1.72],0.7156656142359358
AGER,Advanced glycosylation end product-specific receptor,Chapter IX Diseases of the circulatory system,Other noninfective disorders of lymphatic vessels and lymph nodes,22263,107,1.09 [0.72-1.63],0.6922316817206589
AGER,Advanced glycosylation end product-specific receptor,Chapter IX Diseases of the circulatory system,Other or ill-defined heart diseases,19650,1246,1.38 [1.22-1.56],2.411622491637051e-07
AGER,Advanced glycosylation end product-specific receptor,Chapter IX Diseases of the circulatory system,Other other unspecified disorders of the circulatory system,22344,65,1.46 [0.87-2.46],0.1526127178347103
AGER,Advanced glycosylation end product-specific receptor,Chapter IX Diseases of the circulatory system,Other peripheral vascular diseases,22733,571,1.31 [1.10-1.57],0.0027092875370321
AGER,Advanced glycosylation end product-specific receptor,Chapter IX Diseases of the circulatory system,Other pulmonary heart/vessel disease,23024,364,1.52 [1.23-1.88],0.0001110986078084
AGER,Advanced glycosylation end product-specific receptor,Chapter IX Diseases of the circulatory system,"Other specified cerebrovascular diseases, other cerebrovascular disorders in diseases classified elsewhere",22651,665,1.03 [0.88-1.22],0.6919757738225234
AGER,Advanced glycosylation end product-specific receptor,Chapter IX Diseases of the circulatory system,Paroxysmal tachycardia,11926,379,1.61 [1.29-2.01],2.339834441747959e-05
AGER,Advanced glycosylation end product-specific receptor,Chapter IX Diseases of the circulatory system,Peripheral artery disease,22643,527,1.28 [1.07-1.55],0.0081750593391219
AGER,Advanced glycosylation end product-specific receptor,Chapter IX Diseases of the circulatory system,Phlebitis and thrombophlebitis (not including DVT),22511,355,1.16 [0.92-1.46],0.2009455309560775
AGER,Advanced glycosylation end product-specific receptor,Chapter IX Diseases of the circulatory system,Pulmonary embolism,23151,491,1.08 [0.89-1.31],0.4622397879411682
AGER,Advanced glycosylation end product-specific receptor,Chapter IX Diseases of the circulatory system,Rheumatic valve diseases,23603,712,1.43 [1.22-1.67],7.772093981875765e-06
AGER,Advanced glycosylation end product-specific receptor,Chapter IX Diseases of the circulatory system,Right bundle-branch block,18875,471,1.24 [1.01-1.51],0.0361500022384906
AGER,Advanced glycosylation end product-specific receptor,Chapter IX Diseases of the circulatory system,Secondary right heart disease,23022,362,1.50 [1.21-1.85],0.0002110492915445
AGER,Advanced glycosylation end product-specific receptor,Chapter IX Diseases of the circulatory system,Sequelae of cerebrovascular disease,22211,225,1.12 [0.84-1.49],0.4324027367383074
AGER,Advanced glycosylation end product-specific receptor,Chapter IX Diseases of the circulatory system,"Stroke, excluding SAH",23218,740,1.06 [0.91-1.24],0.4413022900138049
AGER,Advanced glycosylation end product-specific receptor,Chapter IX Diseases of the circulatory system,"Stroke, including SAH",23202,770,1.05 [0.90-1.22],0.5621341298995437
AGER,Advanced glycosylation end product-specific receptor,Chapter IX Diseases of the circulatory system,Subarachnoid haemorrhage,22574,48,0.76 [0.40-1.44],0.4003046727179876
AGER,Advanced glycosylation end product-specific receptor,Chapter IX Diseases of the circulatory system,Thoracic aortic aneurysm,22277,115,1.64 [1.09-2.45],0.016677139048442
AGER,Advanced glycosylation end product-specific receptor,Chapter IX Diseases of the circulatory system,Transient ischemic attack,22835,251,1.11 [0.85-1.45],0.4546876361577753
AGER,Advanced glycosylation end product-specific receptor,Chapter IX Diseases of the circulatory system,Unstable angina pectoris,22196,312,1.10 [0.87-1.40],0.4295274260861716
AGER,Advanced glycosylation end product-specific receptor,Chapter IX Diseases of the circulatory system,Varicose veins,22538,382,1.27 [1.02-1.57],0.0329273514598729
AGER,Advanced glycosylation end product-specific receptor,Chapter IX Diseases of the circulatory system,Vascular diseases of the intestine,22181,73,0.59 [0.35-1.00],0.0481221356380543
AGER,Advanced glycosylation end product-specific receptor,Chapter IX Diseases of the circulatory system,Venous thromboembolism,23424,775,1.11 [0.95-1.29],0.1926422786900259
AGER,Advanced glycosylation end product-specific receptor,Chapter V Mental and behavioural disorders,"Alcohol use disorder, ICD-based",23466,494,0.49 [0.40-0.60],1.2370146435608657e-12
AGER,Advanced glycosylation end product-specific receptor,Chapter V Mental and behavioural disorders,"Anxiety disorders, excluding more controls",20339,960,1.07 [0.93-1.23],0.3600299043287988
AGER,Advanced glycosylation end product-specific receptor,Chapter V Mental and behavioural disorders,Any mental disorder,22980,3601,0.94 [0.87-1.01],0.0698932263549189
AGER,Advanced glycosylation end product-specific receptor,Chapter V Mental and behavioural disorders,"Mental and behavioural disorders due to alcohol, excluding acute intoxication",23405,582,0.48 [0.40-0.57],8.119279252613879e-16
AGER,Advanced glycosylation end product-specific receptor,Chapter V Mental and behavioural disorders,"Mood disorders, excluding more controls",20544,1165,1.08 [0.95-1.22],0.2567026283705922
AGER,Advanced glycosylation end product-specific receptor,Chapter V Mental and behavioural disorders,"Schizophrenia or delusion, excluding more controls",19464,85,0.89 [0.56-1.42],0.6194868631722841
AGER,Advanced glycosylation end product-specific receptor,Chapter V Mental and behavioural disorders,Smoking dependency,23017,1523,0.97 [0.87-1.08],0.6065347347335487
AGER,Advanced glycosylation end product-specific receptor,Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",21236,1857,0.84 [0.76-0.92],0.0004371736087263
AGER,Advanced glycosylation end product-specific receptor,Chapter V Mental and behavioural disorders,Vascular dementia,23154,148,1.08 [0.77-1.53],0.6474522596698589
AGER,Advanced glycosylation end product-specific receptor,Chapter VI Diseases of the nervous system,Alzheimer disease,23661,294,0.88 [0.68-1.13],0.3057250687057432
AGER,Advanced glycosylation end product-specific receptor,Chapter VI Diseases of the nervous system,"Alzheimer√ïs disease (Atypical or mixed), excluding more controls",15718,58,1.49 [0.85-2.62],0.1621398034148005
AGER,Advanced glycosylation end product-specific receptor,Chapter VI Diseases of the nervous system,Bell's palsy,22298,73,1.10 [0.67-1.81],0.7126355325568043
AGER,Advanced glycosylation end product-specific receptor,Chapter VI Diseases of the nervous system,Carpal tunnel syndrome,22564,339,0.78 [0.62-0.99],0.0413037329431906
AGER,Advanced glycosylation end product-specific receptor,Chapter VI Diseases of the nervous system,Cerebral cysts,23255,238,1.12 [0.85-1.49],0.412501247725062
AGER,Advanced glycosylation end product-specific receptor,Chapter VI Diseases of the nervous system,Cerebral palsy and other paralytic syndromes,23578,366,0.96 [0.77-1.20],0.7077319167758247
AGER,Advanced glycosylation end product-specific receptor,Chapter VI Diseases of the nervous system,Circumscribed brain atrophy,23159,60,0.71 [0.40-1.24],0.2268287244808265
AGER,Advanced glycosylation end product-specific receptor,Chapter VI Diseases of the nervous system,Diseases of the myoneural junction and muscle,23643,73,0.94 [0.57-1.55],0.8021149465935902
AGER,Advanced glycosylation end product-specific receptor,Chapter VI Diseases of the nervous system,"Disorders of brain, other and unspecified",23109,92,0.80 [0.51-1.26],0.3384024865696263
AGER,Advanced glycosylation end product-specific receptor,Chapter VI Diseases of the nervous system,Epilepsy,22058,286,0.64 [0.49-0.82],0.0006536314974308
AGER,Advanced glycosylation end product-specific receptor,Chapter VI Diseases of the nervous system,Episodal and paroxysmal disorders,23131,1359,0.97 [0.87-1.10],0.6577149003451658
AGER,Advanced glycosylation end product-specific receptor,Chapter VI Diseases of the nervous system,Extrapyramidal and movement disorders,23626,677,0.81 [0.69-0.96],0.0144070306504191
AGER,Advanced glycosylation end product-specific receptor,Chapter VI Diseases of the nervous system,Falls/tendency to fall,23119,2193,0.98 [0.89-1.07],0.6510669089654452
AGER,Advanced glycosylation end product-specific receptor,Chapter VI Diseases of the nervous system,Generalized epilepsy,23275,59,0.86 [0.49-1.53],0.6109624472588788
AGER,Advanced glycosylation end product-specific receptor,Chapter VI Diseases of the nervous system,Hemiplegia,23494,282,1.01 [0.78-1.30],0.95289141650075
AGER,Advanced glycosylation end product-specific receptor,Chapter VI Diseases of the nervous system,Hydrocephalus,23073,56,0.79 [0.44-1.41],0.4232022161418095
AGER,Advanced glycosylation end product-specific receptor,Chapter VI Diseases of the nervous system,Inflammatory diseases of the central nervous system,23645,58,1.65 [0.96-2.83],0.0703472824202719
AGER,Advanced glycosylation end product-specific receptor,Chapter VI Diseases of the nervous system,Lesion of plantar nerve,22245,20,0.62 [0.23-1.68],0.3499821374518312
AGER,Advanced glycosylation end product-specific receptor,Chapter VI Diseases of the nervous system,Lesion of ulnar nerve,22321,96,1.01 [0.65-1.57],0.9545616321047946
AGER,Advanced glycosylation end product-specific receptor,Chapter VI Diseases of the nervous system,Memory loss,22996,117,0.91 [0.61-1.36],0.6434281158654254
AGER,Advanced glycosylation end product-specific receptor,Chapter VI Diseases of the nervous system,Migraine,21968,196,1.67 [1.23-2.26],0.0010091556638059
AGER,Advanced glycosylation end product-specific receptor,Chapter VI Diseases of the nervous system,"Migraine, unspecified, drug-induced",23638,177,1.81 [1.32-2.48],0.0002073393762181
AGER,Advanced glycosylation end product-specific receptor,Chapter VI Diseases of the nervous system,Motor neuron disease,15825,152,0.82 [0.57-1.18],0.2833717788744693
AGER,Advanced glycosylation end product-specific receptor,Chapter VI Diseases of the nervous system,MS-disease / Multiple Sclerosis,23551,64,0.93 [0.53-1.62],0.791568419347631
AGER,Advanced glycosylation end product-specific receptor,Chapter VI Diseases of the nervous system,"Nerve, nerve root and plexus disorders",23196,971,0.91 [0.80-1.05],0.2053963941711053
AGER,Advanced glycosylation end product-specific receptor,Chapter VI Diseases of the nervous system,Neurological diseases,22358,3658,0.98 [0.91-1.05],0.5166609490311487
AGER,Advanced glycosylation end product-specific receptor,Chapter VI Diseases of the nervous system,Other and unspecified degenerative diseases of nervous system,23336,237,0.77 [0.59-1.02],0.0738254959147245
AGER,Advanced glycosylation end product-specific receptor,Chapter VI Diseases of the nervous system,"Other and unspecified nerve root and plexus disorders, also in other diseases",22614,389,1.07 [0.86-1.33],0.5482340176997479
AGER,Advanced glycosylation end product-specific receptor,Chapter VI Diseases of the nervous system,"Other and unspecified polyneuropathies, also in other diseases",23570,349,1.44 [1.16-1.80],0.0012233794973092
AGER,Advanced glycosylation end product-specific receptor,Chapter VI Diseases of the nervous system,Other degenerative diseases of the nervous system,18544,616,0.86 [0.72-1.02],0.0872771529017334
AGER,Advanced glycosylation end product-specific receptor,Chapter VI Diseases of the nervous system,Other diseases of spinal cord,23097,80,0.83 [0.51-1.36],0.4673225810919562
AGER,Advanced glycosylation end product-specific receptor,Chapter VI Diseases of the nervous system,Other disorders of nervous system,23172,155,1.16 [0.83-1.63],0.385638065948353
AGER,Advanced glycosylation end product-specific receptor,Chapter VI Diseases of the nervous system,Other extrapyramidal and movement disorders in other diseases,23085,136,1.10 [0.76-1.58],0.6275589241305516
AGER,Advanced glycosylation end product-specific receptor,Chapter VI Diseases of the nervous system,Other facial nerve disorders,22317,92,1.24 [0.80-1.93],0.3367382067975941
AGER,Advanced glycosylation end product-specific receptor,Chapter VI Diseases of the nervous system,Other headache syndromes,21809,37,0.74 [0.36-1.53],0.4190733508291004
AGER,Advanced glycosylation end product-specific receptor,Chapter VI Diseases of the nervous system,Other neurological diseases,23543,526,1.04 [0.86-1.26],0.6774740412678761
AGER,Advanced glycosylation end product-specific receptor,Chapter VI Diseases of the nervous system,Other sleep disorders,22469,697,0.98 [0.83-1.15],0.8082795836604061
AGER,Advanced glycosylation end product-specific receptor,Chapter VI Diseases of the nervous system,Parkinson's disease,23640,532,0.75 [0.62-0.91],0.0029398842306769
AGER,Advanced glycosylation end product-specific receptor,Chapter VI Diseases of the nervous system,Postviral fatigue syndrome,23045,28,2.75 [1.36-5.56],0.0047224804742031
AGER,Advanced glycosylation end product-specific receptor,Chapter VI Diseases of the nervous system,Restless leg syndrome,23662,46,0.93 [0.49-1.76],0.8161089641014149
AGER,Advanced glycosylation end product-specific receptor,Chapter VI Diseases of the nervous system,Sleep apnoea,23361,627,0.95 [0.80-1.12],0.5242475790670876
AGER,Advanced glycosylation end product-specific receptor,Chapter VI Diseases of the nervous system,Small fibre neuropathy,23279,58,1.57 [0.91-2.73],0.1065594144368838
AGER,Advanced glycosylation end product-specific receptor,Chapter VI Diseases of the nervous system,Systemic atrophies primarily affecting the central nervous system,23644,178,0.90 [0.65-1.24],0.5112536250426585
AGER,Advanced glycosylation end product-specific receptor,Chapter VI Diseases of the nervous system,Trigeminal neuralgia,22260,35,1.60 [0.80-3.21],0.1866614835799423
AGER,Advanced glycosylation end product-specific receptor,Chapter VI Diseases of the nervous system,Unspecific neurodegenerative disorder,23661,297,0.87 [0.68-1.11],0.2549059918141892
AGER,Advanced glycosylation end product-specific receptor,Chapter VI Diseases of the nervous system,Vascular dementia (undefined),23123,144,1.12 [0.79-1.59],0.5164766459012324
AGER,Advanced glycosylation end product-specific receptor,"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Amblyopia ex anopsia,23113,88,0.77 [0.48-1.22],0.2625438834618352
AGER,Advanced glycosylation end product-specific receptor,"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Astigmatism,23320,300,0.93 [0.72-1.19],0.554785675151096
AGER,Advanced glycosylation end product-specific receptor,"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Background diabetic retinopathy,23462,290,0.99 [0.78-1.27],0.9534862029314528
AGER,Advanced glycosylation end product-specific receptor,"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Blepharochalasis,22793,44,0.79 [0.41-1.51],0.4726097852595202
AGER,Advanced glycosylation end product-specific receptor,"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Chalazion,22808,59,1.07 [0.61-1.88],0.8042063261635976
AGER,Advanced glycosylation end product-specific receptor,"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Conjunctivitis (acute, non atopic)",23573,43,1.00 [0.52-1.91],0.9993420226433032
AGER,Advanced glycosylation end product-specific receptor,"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Corneal degeneration,23432,124,1.10 [0.75-1.61],0.6247282543936812
AGER,Advanced glycosylation end product-specific receptor,"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic nephropathy, excluding more controls",2459,83,4.35 [2.97-6.38],5.4478661917350304e-14
AGER,Advanced glycosylation end product-specific receptor,"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Diabetic neuropathy,2993,128,1.67 [1.18-2.37],0.003893763383532
AGER,Advanced glycosylation end product-specific receptor,"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Diplopia,23116,91,1.15 [0.73-1.80],0.5462523822407974
AGER,Advanced glycosylation end product-specific receptor,"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Disorders of choroid and retina,23415,992,0.91 [0.79-1.04],0.1685761236312304
AGER,Advanced glycosylation end product-specific receptor,"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Disorders of eyelid, lacrimal system and orbit",23359,610,0.92 [0.77-1.09],0.3186706000611212
AGER,Advanced glycosylation end product-specific receptor,"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Disorders of lacrimal system,22891,142,1.13 [0.79-1.60],0.5124329449891554
AGER,Advanced glycosylation end product-specific receptor,"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Disorders of ocular muscles, binocular movement, accommodation and refraction",23587,567,1.05 [0.87-1.26],0.6188076069770652
AGER,Advanced glycosylation end product-specific receptor,"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Disorders of optic nerve and visual pathways,23659,63,0.88 [0.51-1.53],0.6537810540334557
AGER,Advanced glycosylation end product-specific receptor,"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Disorders of refraction and accommodation,23521,501,1.06 [0.88-1.29],0.5329279865030663
AGER,Advanced glycosylation end product-specific receptor,"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Disorders of sclera, cornea, iris and ciliary body",23622,314,1.00 [0.79-1.27],0.9945802814279292
AGER,Advanced glycosylation end product-specific receptor,"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Disorders of vitreous body,23571,148,0.76 [0.53-1.09],0.1338128076564766
AGER,Advanced glycosylation end product-specific receptor,"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Ectropion of eyelid,22828,79,0.70 [0.43-1.14],0.1509031084780967
AGER,Advanced glycosylation end product-specific receptor,"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Entropion and trichiasis of eyelid,22835,86,0.99 [0.63-1.57],0.9674058517020366
AGER,Advanced glycosylation end product-specific receptor,"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Epiphora,22792,43,0.57 [0.30-1.10],0.0933398056464927
AGER,Advanced glycosylation end product-specific receptor,"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Glaucoma,23568,673,0.98 [0.83-1.15],0.8074295255004751
AGER,Advanced glycosylation end product-specific receptor,"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Glaucoma suspect,23077,182,1.10 [0.80-1.50],0.5701312780115648
AGER,Advanced glycosylation end product-specific receptor,"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Hypermetropia,23049,29,2.46 [1.20-5.05],0.0139769606740662
AGER,Advanced glycosylation end product-specific receptor,"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Iridocyclitis,23405,97,1.02 [0.66-1.57],0.9362021023269322
AGER,Advanced glycosylation end product-specific receptor,"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Keratitis,23531,223,1.04 [0.78-1.39],0.785142356171924
AGER,Advanced glycosylation end product-specific receptor,"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Myopia,23191,171,1.23 [0.89-1.72],0.2108881042446315
AGER,Advanced glycosylation end product-specific receptor,"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Other and unspecified disorders of vitreous body,23506,83,0.63 [0.39-1.03],0.0655087418082756
AGER,Advanced glycosylation end product-specific receptor,"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Other and unspecified glaucoma,23348,453,0.96 [0.79-1.17],0.6868356817139489
AGER,Advanced glycosylation end product-specific receptor,"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Other and unspecified visual disturbances,23156,131,1.13 [0.78-1.64],0.5090774418975574
AGER,Advanced glycosylation end product-specific receptor,"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Other cataract,22284,1780,0.97 [0.87-1.07],0.4929754817906611
AGER,Advanced glycosylation end product-specific receptor,"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Other disorders of cornea,23502,194,1.10 [0.81-1.49],0.5598568546565714
AGER,Advanced glycosylation end product-specific receptor,"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Other disorders of eye and adnexa,23646,145,1.15 [0.81-1.63],0.4478954015289549
AGER,Advanced glycosylation end product-specific receptor,"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Other disorders of eyelid,23166,417,0.82 [0.66-1.01],0.0631846051769118
AGER,Advanced glycosylation end product-specific receptor,"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Other disorders of iris and ciliary body,23374,66,1.31 [0.78-2.20],0.2998607544892623
AGER,Advanced glycosylation end product-specific receptor,"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Other disorders of optic [2nd] nerve and visual pathways,23650,54,0.79 [0.44-1.42],0.4282766410592227
AGER,Advanced glycosylation end product-specific receptor,"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Other inflammation of eyelid,22825,76,1.03 [0.63-1.67],0.9144603849775896
AGER,Advanced glycosylation end product-specific receptor,"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Other specified and unspecified  disorders of eyelid,22886,137,0.72 [0.50-1.05],0.0857486273614392
AGER,Advanced glycosylation end product-specific receptor,"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Other specified and unspecified retinal disorders,22547,124,0.82 [0.56-1.21],0.3228792088713792
AGER,Advanced glycosylation end product-specific receptor,"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Other strabismus,23068,48,1.30 [0.70-2.41],0.4128603171626478
AGER,Advanced glycosylation end product-specific receptor,"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Other, unspecified and serous retinal detachments",22486,63,0.74 [0.42-1.30],0.2941339018279563
AGER,Advanced glycosylation end product-specific receptor,"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Primary angle-closure glaucoma,22945,50,0.99 [0.53-1.83],0.9671701809210532
AGER,Advanced glycosylation end product-specific receptor,"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Primary open-angle glaucoma, strict",23104,209,0.93 [0.70-1.26],0.6520583480983673
AGER,Advanced glycosylation end product-specific receptor,"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Ptosis of eyelid,22867,118,1.00 [0.68-1.48],0.9882794855245832
AGER,Advanced glycosylation end product-specific receptor,"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Retinal detachment with retinal break,22543,120,0.90 [0.60-1.35],0.6082565248309424
AGER,Advanced glycosylation end product-specific receptor,"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Retinal vascular occlusion,22515,92,0.85 [0.54-1.34],0.4853927575130901
AGER,Advanced glycosylation end product-specific receptor,"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Senile cataract,21973,1469,1.07 [0.96-1.19],0.2469634912359003
AGER,Advanced glycosylation end product-specific receptor,"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Stenosis and insufficiency of lacrimal passages,22806,57,1.25 [0.72-2.16],0.4217256333990146
AGER,Advanced glycosylation end product-specific receptor,"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual disturbances,23416,391,0.94 [0.76-1.17],0.5933497107106784
AGER,Advanced glycosylation end product-specific receptor,"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual field defects,23096,71,0.67 [0.41-1.12],0.1271571862636505
AGER,Advanced glycosylation end product-specific receptor,"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual impairment including blindness (binocular or monocular),23193,168,1.19 [0.86-1.65],0.3014428670480873
AGER,Advanced glycosylation end product-specific receptor,Chapter VIII Diseases of the ear and mastoid process,Benign paroxysmal vertigo,23487,57,1.23 [0.70-2.17],0.466870508721841
AGER,Advanced glycosylation end product-specific receptor,Chapter VIII Diseases of the ear and mastoid process,Diseases of external ear,23620,121,1.39 [0.95-2.03],0.0936894208187155
AGER,Advanced glycosylation end product-specific receptor,Chapter VIII Diseases of the ear and mastoid process,Diseases of middle ear and mastoid,23532,110,1.28 [0.86-1.91],0.2271939637809442
AGER,Advanced glycosylation end product-specific receptor,Chapter VIII Diseases of the ear and mastoid process,Labyrinthitis,23480,50,1.60 [0.89-2.89],0.1187098914586332
AGER,Advanced glycosylation end product-specific receptor,Chapter VIII Diseases of the ear and mastoid process,M¬éni¬ère disease,23482,52,1.00 [0.55-1.82],0.9960172838631968
AGER,Advanced glycosylation end product-specific receptor,Chapter VIII Diseases of the ear and mastoid process,Other disorders of ear,23571,960,1.11 [0.97-1.28],0.1336150913282462
AGER,Advanced glycosylation end product-specific receptor,Chapter VIII Diseases of the ear and mastoid process,Other specified/unspecified hearing loss,23325,714,1.13 [0.96-1.33],0.1331820762808326
AGER,Advanced glycosylation end product-specific receptor,Chapter VIII Diseases of the ear and mastoid process,Sensorineural hearing loss,22742,131,0.98 [0.67-1.43],0.922967162745138
AGER,Advanced glycosylation end product-specific receptor,Chapter VIII Diseases of the ear and mastoid process,Tinnitus,22692,81,1.27 [0.79-2.03],0.3266320971618638
AGER,Advanced glycosylation end product-specific receptor,Chapter X Diseases of the respiratory system,Acute pharyngitis,23452,63,1.51 [0.89-2.56],0.1306452577249715
AGER,Advanced glycosylation end product-specific receptor,Chapter X Diseases of the respiratory system,Acute upper respiratory infections,23577,188,1.43 [1.05-1.94],0.0219689568862847
AGER,Advanced glycosylation end product-specific receptor,Chapter X Diseases of the respiratory system,Acute upper respiratory infections of multiple and unspecified sites,23449,60,1.75 [1.05-2.93],0.0330673436552993
AGER,Advanced glycosylation end product-specific receptor,Chapter X Diseases of the respiratory system,All influenza,21375,109,1.40 [0.93-2.12],0.110317619771587
AGER,Advanced glycosylation end product-specific receptor,Chapter X Diseases of the respiratory system,All influenza (not pneumonia),21372,106,1.45 [0.95-2.20],0.0819341039239803
AGER,Advanced glycosylation end product-specific receptor,Chapter X Diseases of the respiratory system,Allergic asthma (mode),15504,104,0.94 [0.61-1.47],0.7934991166387902
AGER,Advanced glycosylation end product-specific receptor,Chapter X Diseases of the respiratory system,Allergic rhinitis,23554,265,0.91 [0.70-1.19],0.4993452458559106
AGER,Advanced glycosylation end product-specific receptor,Chapter X Diseases of the respiratory system,"Asthma, excluding more controls",16476,1424,0.83 [0.73-0.93],0.0019731268767461
AGER,Advanced glycosylation end product-specific receptor,Chapter X Diseases of the respiratory system,"Asthma, unspecified (mode)",16799,1399,0.82 [0.73-0.93],0.0014510491068736
AGER,Advanced glycosylation end product-specific receptor,Chapter X Diseases of the respiratory system,Bacterial pneumonia (organism specified),23277,150,1.40 [1.00-1.97],0.0522163166456798
AGER,Advanced glycosylation end product-specific receptor,Chapter X Diseases of the respiratory system,"Bacterial pneumonia, not elsewhere classified",21361,95,1.45 [0.94-2.23],0.0951422199861068
AGER,Advanced glycosylation end product-specific receptor,Chapter X Diseases of the respiratory system,Bronchiectasis,20564,288,0.56 [0.43-0.72],9.794533137383351e-06
AGER,Advanced glycosylation end product-specific receptor,Chapter X Diseases of the respiratory system,"Bronchitis, not specified as acute or chronic",20319,43,1.14 [0.59-2.20],0.7002307784197694
AGER,Advanced glycosylation end product-specific receptor,Chapter X Diseases of the respiratory system,Chronic lower respiratory diseases,22811,2535,0.78 [0.71-0.85],1.8648040113560704e-08
AGER,Advanced glycosylation end product-specific receptor,Chapter X Diseases of the respiratory system,"Chronic rhinitis, nasopharyngitis and pharyngitis",22226,78,1.07 [0.65-1.75],0.7944507084129788
AGER,Advanced glycosylation end product-specific receptor,Chapter X Diseases of the respiratory system,Chronic sinusitis,22308,160,0.86 [0.61-1.22],0.3995896323866373
AGER,Advanced glycosylation end product-specific receptor,Chapter X Diseases of the respiratory system,"COPD, hospital admissions 1, only main diagnosis",23437,1293,0.59 [0.52-0.67],1.2992467469212801e-17
AGER,Advanced glycosylation end product-specific receptor,Chapter X Diseases of the respiratory system,Deviated nasal septum,22287,139,1.23 [0.85-1.78],0.2731346228650997
AGER,Advanced glycosylation end product-specific receptor,Chapter X Diseases of the respiratory system,Diseases of the respiratory system,21660,5237,0.96 [0.91-1.02],0.2205590448548096
AGER,Advanced glycosylation end product-specific receptor,Chapter X Diseases of the respiratory system,"Diseases of vocal cords and larynx+other diseases of upper respiratory tract, no elsewhere classified",22538,390,1.10 [0.88-1.37],0.396595218634142
AGER,Advanced glycosylation end product-specific receptor,Chapter X Diseases of the respiratory system,Early onset COPD,22447,303,0.49 [0.38-0.63],3.8767017547993135e-08
AGER,Advanced glycosylation end product-specific receptor,Chapter X Diseases of the respiratory system,Emphysema,20622,346,0.56 [0.44-0.71],1.1087999274865325e-06
AGER,Advanced glycosylation end product-specific receptor,Chapter X Diseases of the respiratory system,Idiopathic pulmonary fibrosis,22734,333,0.52 [0.41-0.66],1.0080161231758997e-07
AGER,Advanced glycosylation end product-specific receptor,Chapter X Diseases of the respiratory system,Influenza and pneumonia,23412,2146,0.99 [0.90-1.08],0.7772137295642803
AGER,Advanced glycosylation end product-specific receptor,Chapter X Diseases of the respiratory system,Interstitial lung disease,22763,362,0.59 [0.47-0.74],4.333990977880642e-06
AGER,Advanced glycosylation end product-specific receptor,Chapter X Diseases of the respiratory system,Later onset COPD,22596,990,0.60 [0.52-0.69],4.085058214426086e-13
AGER,Advanced glycosylation end product-specific receptor,Chapter X Diseases of the respiratory system,Lung diseases due to external agents,23645,425,1.11 [0.91-1.37],0.3059078021182931
AGER,Advanced glycosylation end product-specific receptor,Chapter X Diseases of the respiratory system,Nasal polyp,22292,144,1.36 [0.95-1.94],0.0930014132032708
AGER,Advanced glycosylation end product-specific receptor,Chapter X Diseases of the respiratory system,Other acute lower respiratory infections,23397,993,1.10 [0.96-1.26],0.161175345699788
AGER,Advanced glycosylation end product-specific receptor,Chapter X Diseases of the respiratory system,Other diseases of pleura,23383,2178,0.99 [0.90-1.08],0.7823170873935892
AGER,Advanced glycosylation end product-specific receptor,Chapter X Diseases of the respiratory system,Other diseases of upper respiratory tract,23013,865,1.03 [0.89-1.19],0.6853507068118649
AGER,Advanced glycosylation end product-specific receptor,Chapter X Diseases of the respiratory system,Other pleural conditions,21270,65,0.91 [0.53-1.58],0.7452627422020339
AGER,Advanced glycosylation end product-specific receptor,Chapter X Diseases of the respiratory system,Other respiratory diseases principally affecting the interstitium,23567,446,0.71 [0.58-0.87],0.0008756463561221
AGER,Advanced glycosylation end product-specific receptor,Chapter X Diseases of the respiratory system,Other respiratory disorders and diseases,23539,1376,0.90 [0.81-1.02],0.0910893356188444
AGER,Advanced glycosylation end product-specific receptor,Chapter X Diseases of the respiratory system,Pleural effusion,22323,1118,1.23 [1.08-1.40],0.0014468723716483
AGER,Advanced glycosylation end product-specific receptor,Chapter X Diseases of the respiratory system,Pleural plaque,21468,263,1.05 [0.81-1.37],0.6996116551712894
AGER,Advanced glycosylation end product-specific receptor,Chapter X Diseases of the respiratory system,"Pneumonia, organism unspecified",23149,1883,0.95 [0.86-1.05],0.3510661670195912
AGER,Advanced glycosylation end product-specific receptor,Chapter X Diseases of the respiratory system,Pneumonitis due to solids and liquids,23543,323,1.11 [0.87-1.40],0.4070638598736866
AGER,Advanced glycosylation end product-specific receptor,Chapter X Diseases of the respiratory system,Pneumothorax,21344,139,0.97 [0.67-1.41],0.8931284240448567
AGER,Advanced glycosylation end product-specific receptor,Chapter X Diseases of the respiratory system,Pollen allergy,23646,230,0.97 [0.73-1.29],0.8238732033970887
AGER,Advanced glycosylation end product-specific receptor,Chapter X Diseases of the respiratory system,Pulmonary oedema,23189,68,1.70 [1.04-2.76],0.0331838249645619
AGER,Advanced glycosylation end product-specific receptor,Chapter X Diseases of the respiratory system,Respiratory insufficiency,15456,56,0.58 [0.32-1.04],0.0691938492419287
AGER,Advanced glycosylation end product-specific receptor,Chapter X Diseases of the respiratory system,Unspecified acute lower respiratory infection,23379,975,1.08 [0.94-1.24],0.2556944536673682
AGER,Advanced glycosylation end product-specific receptor,Chapter X Diseases of the respiratory system,Vasomotor and allergic rhinitis,22414,266,0.91 [0.69-1.19],0.4714750319348532
AGER,Advanced glycosylation end product-specific receptor,Chapter X Diseases of the respiratory system,Viral pneumonia,21546,280,1.39 [1.07-1.79],0.0119764324470507
AGER,Advanced glycosylation end product-specific receptor,Chapter X Diseases of the respiratory system,"Viral pneumonia (unknown virus, not influenza)",23295,237,1.38 [1.05-1.81],0.0192443103268574
AGER,Advanced glycosylation end product-specific receptor,Chapter X Diseases of the respiratory system,Vocal cord dysfunction,10300,118,0.89 [0.59-1.33],0.5533396443055436
AGER,Advanced glycosylation end product-specific receptor,Chapter XI Diseases of the digestive system,Abscess of anal and rectal regions,16509,89,1.24 [0.79-1.95],0.3525062568957521
AGER,Advanced glycosylation end product-specific receptor,Chapter XI Diseases of the digestive system,Acute appendicitis,23526,144,0.89 [0.62-1.29],0.53702903786553
AGER,Advanced glycosylation end product-specific receptor,Chapter XI Diseases of the digestive system,Acute gastritis,17853,90,1.66 [1.07-2.57],0.022447740536547
AGER,Advanced glycosylation end product-specific receptor,Chapter XI Diseases of the digestive system,Acute pancreatitis,22311,202,1.05 [0.77-1.42],0.7517474032179428
AGER,Advanced glycosylation end product-specific receptor,Chapter XI Diseases of the digestive system,Acute peritonitis,23307,100,1.96 [1.32-2.92],0.0009126579322044
AGER,Advanced glycosylation end product-specific receptor,Chapter XI Diseases of the digestive system,Alcoholic liver disease,22767,116,0.76 [0.51-1.13],0.1729311438836995
AGER,Advanced glycosylation end product-specific receptor,Chapter XI Diseases of the digestive system,Barrett oesophagus,18286,523,1.27 [1.05-1.53],0.0140509014943026
AGER,Advanced glycosylation end product-specific receptor,Chapter XI Diseases of the digestive system,"Cholangitis (primary sclerosing, PSC)",22229,120,1.32 [0.89-1.94],0.1661641676165709
AGER,Advanced glycosylation end product-specific receptor,Chapter XI Diseases of the digestive system,"Cholangitis (primary sclerosing, PSC), with reimbursement 202",23257,120,1.30 [0.89-1.91],0.1809982624914796
AGER,Advanced glycosylation end product-specific receptor,Chapter XI Diseases of the digestive system,Cholecystitis,22327,218,1.07 [0.80-1.44],0.6405890940735819
AGER,Advanced glycosylation end product-specific receptor,Chapter XI Diseases of the digestive system,Cholelithiasis,22893,784,1.26 [1.08-1.47],0.002977071925777
AGER,Advanced glycosylation end product-specific receptor,Chapter XI Diseases of the digestive system,Chronic gastritis,18027,264,1.59 [1.23-2.05],0.0003560817851192
AGER,Advanced glycosylation end product-specific receptor,Chapter XI Diseases of the digestive system,Chronic pancreatitis,22165,56,0.67 [0.38-1.19],0.1686276507006241
AGER,Advanced glycosylation end product-specific receptor,Chapter XI Diseases of the digestive system,"Cirrhosis of liver, NAS",23454,136,1.50 [1.06-2.14],0.0226960484356213
AGER,Advanced glycosylation end product-specific receptor,Chapter XI Diseases of the digestive system,Coeliac disease,22033,95,0.73 [0.46-1.15],0.1701961024776724
AGER,Advanced glycosylation end product-specific receptor,Chapter XI Diseases of the digestive system,Collagenous colitis,22229,47,1.07 [0.57-2.00],0.8383849681448031
AGER,Advanced glycosylation end product-specific receptor,Chapter XI Diseases of the digestive system,Colonic or urogenital fistula,23494,220,0.94 [0.71-1.26],0.7006895496582375
AGER,Advanced glycosylation end product-specific receptor,Chapter XI Diseases of the digestive system,Constipation,23499,1582,1.07 [0.96-1.19],0.2142716810946731
AGER,Advanced glycosylation end product-specific receptor,Chapter XI Diseases of the digestive system,Crohn disease,22274,92,1.24 [0.79-1.94],0.3457323206176098
AGER,Advanced glycosylation end product-specific receptor,Chapter XI Diseases of the digestive system,"Crohn disease (strict definition, all UC cases excluded)",23319,66,1.23 [0.73-2.09],0.4377213053837757
AGER,Advanced glycosylation end product-specific receptor,Chapter XI Diseases of the digestive system,Crohn's disease NAS,22260,78,2.07 [1.31-3.28],0.001818360049837
AGER,Advanced glycosylation end product-specific receptor,Chapter XI Diseases of the digestive system,Dental caries,23018,228,1.31 [0.99-1.73],0.0627006664388997
AGER,Advanced glycosylation end product-specific receptor,Chapter XI Diseases of the digestive system,Diaphragmatic hernia,20044,1941,1.09 [0.99-1.21],0.073308927413915
AGER,Advanced glycosylation end product-specific receptor,Chapter XI Diseases of the digestive system,Diseases of appendix,23557,175,0.88 [0.63-1.22],0.4379866631923106
AGER,Advanced glycosylation end product-specific receptor,Chapter XI Diseases of the digestive system,Diseases of liver,23520,869,1.02 [0.88-1.18],0.8252241457964176
AGER,Advanced glycosylation end product-specific receptor,Chapter XI Diseases of the digestive system,"Diseases of oesophagus, stomach and duodenum",21678,3915,1.17 [1.09-1.25],9.722137708326638e-06
AGER,Advanced glycosylation end product-specific receptor,Chapter XI Diseases of the digestive system,"Diseases of oral cavity, salivary glands and jaws",23303,513,1.26 [1.04-1.52],0.0160011455615515
AGER,Advanced glycosylation end product-specific receptor,Chapter XI Diseases of the digestive system,Diseases of peritoneum,23612,405,1.17 [0.94-1.44],0.1529118375212018
AGER,Advanced glycosylation end product-specific receptor,Chapter XI Diseases of the digestive system,Diseases of pulp and periapical tissues,22901,111,1.15 [0.76-1.72],0.5119898701162576
AGER,Advanced glycosylation end product-specific receptor,Chapter XI Diseases of the digestive system,Diseases of salivary glands,22757,67,1.07 [0.63-1.81],0.7986595709391131
AGER,Advanced glycosylation end product-specific receptor,Chapter XI Diseases of the digestive system,Diseases of the digestive system,23346,1408,1.08 [0.97-1.21],0.173714323589756
AGER,Advanced glycosylation end product-specific receptor,Chapter XI Diseases of the digestive system,Diseases of tongue,22777,107,1.35 [0.89-2.05],0.1516612589901685
AGER,Advanced glycosylation end product-specific receptor,Chapter XI Diseases of the digestive system,"Disorders of gallbladder, biliary tract and pancreas",23292,1183,1.17 [1.04-1.33],0.0112681725120176
AGER,Advanced glycosylation end product-specific receptor,Chapter XI Diseases of the digestive system,Diverticular disease of intestine,19453,3033,0.94 [0.87-1.02],0.1292877341087495
AGER,Advanced glycosylation end product-specific receptor,Chapter XI Diseases of the digestive system,Duodenal ulcer,18028,265,1.02 [0.78-1.33],0.870208822935707
AGER,Advanced glycosylation end product-specific receptor,Chapter XI Diseases of the digestive system,"Duodenal ulcer - Unspecified as acute or chronic, without haemorrhage or perforation, drug-induced",23546,209,0.88 [0.65-1.18],0.3851777534513684
AGER,Advanced glycosylation end product-specific receptor,Chapter XI Diseases of the digestive system,Embedded and impacted teeth,23587,45,0.88 [0.46-1.69],0.7000624081410622
AGER,Advanced glycosylation end product-specific receptor,Chapter XI Diseases of the digestive system,Fibrosis and cirrhosis of liver,22810,159,1.46 [1.05-2.03],0.0227805479380005
AGER,Advanced glycosylation end product-specific receptor,Chapter XI Diseases of the digestive system,Fissure and fistula of anal and rectal regions,16599,179,1.02 [0.74-1.40],0.9173143491862488
AGER,Advanced glycosylation end product-specific receptor,Chapter XI Diseases of the digestive system,Functional dyspepsia,18187,424,1.10 [0.89-1.35],0.3958281286909235
AGER,Advanced glycosylation end product-specific receptor,Chapter XI Diseases of the digestive system,Gastric ulcer,18126,363,1.53 [1.23-1.91],0.0001348552227448
AGER,Advanced glycosylation end product-specific receptor,Chapter XI Diseases of the digestive system,Gastro-oesophageal reflux disease,19908,2145,1.07 [0.98-1.18],0.1455163529265872
AGER,Advanced glycosylation end product-specific receptor,Chapter XI Diseases of the digestive system,Gastroduodenal ulcer,18354,591,1.22 [1.03-1.46],0.0239355507904379
AGER,Advanced glycosylation end product-specific receptor,Chapter XI Diseases of the digestive system,Gastrointestinal diseases,18065,7928,1.01 [0.96-1.06],0.598311732775777
AGER,Advanced glycosylation end product-specific receptor,Chapter XI Diseases of the digestive system,GI-bleeding,23108,1170,1.13 [1.00-1.28],0.0571920009018556
AGER,Advanced glycosylation end product-specific receptor,Chapter XI Diseases of the digestive system,Gingivitis and periodontal diseases,22836,46,0.94 [0.49-1.78],0.8404820124707342
AGER,Advanced glycosylation end product-specific receptor,Chapter XI Diseases of the digestive system,Haemorrhoids and perianal venous thrombosis,17387,1233,1.09 [0.96-1.24],0.1675100913954295
AGER,Advanced glycosylation end product-specific receptor,Chapter XI Diseases of the digestive system,"Hepatic failure, not elsewhere classified",22737,86,0.92 [0.58-1.46],0.7170491959906764
AGER,Advanced glycosylation end product-specific receptor,Chapter XI Diseases of the digestive system,Hernia,21612,3509,1.00 [0.93-1.08],0.9934553144263232
AGER,Advanced glycosylation end product-specific receptor,Chapter XI Diseases of the digestive system,Impacted teeth,23590,42,0.79 [0.40-1.55],0.4853344156910443
AGER,Advanced glycosylation end product-specific receptor,Chapter XI Diseases of the digestive system,Impaction of intestines,16465,45,2.19 [1.20-3.99],0.0105869240394774
AGER,Advanced glycosylation end product-specific receptor,Chapter XI Diseases of the digestive system,Inguinal hernia,19717,1614,0.93 [0.83-1.04],0.1843149562162593
AGER,Advanced glycosylation end product-specific receptor,Chapter XI Diseases of the digestive system,"Inguinal hernia, bilateral",18297,194,0.89 [0.65-1.22],0.4540084489227963
AGER,Advanced glycosylation end product-specific receptor,Chapter XI Diseases of the digestive system,Intestinal adhesions without obstruction,16508,88,0.79 [0.50-1.26],0.3170531290751273
AGER,Advanced glycosylation end product-specific receptor,Chapter XI Diseases of the digestive system,Intestinal malabsorption,22046,108,0.76 [0.50-1.17],0.2142373015226042
AGER,Advanced glycosylation end product-specific receptor,Chapter XI Diseases of the digestive system,Irritable bowel syndrome,16691,271,0.99 [0.76-1.30],0.9592810777665448
AGER,Advanced glycosylation end product-specific receptor,Chapter XI Diseases of the digestive system,Nonalcoholic fatty liver disease,23619,375,0.90 [0.72-1.13],0.3586046374733046
AGER,Advanced glycosylation end product-specific receptor,Chapter XI Diseases of the digestive system,Noninfectious colitis NAS,22857,675,1.25 [1.06-1.47],0.0075528193391462
AGER,Advanced glycosylation end product-specific receptor,Chapter XI Diseases of the digestive system,Noninfective enteritis and colitis,23062,880,1.25 [1.08-1.44],0.0024333335250065
AGER,Advanced glycosylation end product-specific receptor,Chapter XI Diseases of the digestive system,Oesophageal obstruction,17977,214,1.08 [0.80-1.45],0.6021377769807748
AGER,Advanced glycosylation end product-specific receptor,Chapter XI Diseases of the digestive system,Oesophagitis,18392,629,1.35 [1.14-1.59],0.0005890393097672
AGER,Advanced glycosylation end product-specific receptor,Chapter XI Diseases of the digestive system,Oral lichen ruber planus,23611,113,0.76 [0.50-1.14],0.1872252985215252
AGER,Advanced glycosylation end product-specific receptor,Chapter XI Diseases of the digestive system,Other and unspecified abdominal hernia,18174,71,1.78 [1.10-2.90],0.0197712365039459
AGER,Advanced glycosylation end product-specific receptor,Chapter XI Diseases of the digestive system,Other diseases of anus and rectum,17844,1424,1.07 [0.95-1.20],0.265076628140806
AGER,Advanced glycosylation end product-specific receptor,Chapter XI Diseases of the digestive system,Other diseases of biliary tract,22367,258,1.05 [0.80-1.38],0.7104455797245037
AGER,Advanced glycosylation end product-specific receptor,Chapter XI Diseases of the digestive system,Other diseases of gallbladder,22231,122,0.94 [0.63-1.39],0.7425373253183507
AGER,Advanced glycosylation end product-specific receptor,Chapter XI Diseases of the digestive system,Other diseases of intestine,18290,1870,0.94 [0.85-1.04],0.25217076575771
AGER,Advanced glycosylation end product-specific receptor,Chapter XI Diseases of the digestive system,Other diseases of intestines,21848,5428,1.00 [0.95-1.06],0.8976688804473205
AGER,Advanced glycosylation end product-specific receptor,Chapter XI Diseases of the digestive system,Other diseases of lip and oral mucosa,22742,179,0.82 [0.59-1.14],0.2418562123665892
AGER,Advanced glycosylation end product-specific receptor,Chapter XI Diseases of the digestive system,Other diseases of liver,23344,693,1.08 [0.92-1.28],0.324562689326263
AGER,Advanced glycosylation end product-specific receptor,Chapter XI Diseases of the digestive system,Other diseases of oesophagus,18493,730,1.27 [1.09-1.49],0.0028038022906514
AGER,Advanced glycosylation end product-specific receptor,Chapter XI Diseases of the digestive system,Other diseases of pancreas,22251,142,1.32 [0.92-1.88],0.1299878387326204
AGER,Advanced glycosylation end product-specific receptor,Chapter XI Diseases of the digestive system,Other diseases of peritoneum,23538,331,1.01 [0.80-1.28],0.922699703445283
AGER,Advanced glycosylation end product-specific receptor,Chapter XI Diseases of the digestive system,Other diseases of stomach and duodenum,18566,803,1.37 [1.17-1.59],5.0003652927851856e-05
AGER,Advanced glycosylation end product-specific receptor,Chapter XI Diseases of the digestive system,Other diseases of the digestive system,23120,1182,1.12 [0.99-1.27],0.0663801732964632
AGER,Advanced glycosylation end product-specific receptor,Chapter XI Diseases of the digestive system,Other disorders of teeth and supporting structures,22968,178,1.47 [1.08-2.01],0.0153558557607236
AGER,Advanced glycosylation end product-specific receptor,Chapter XI Diseases of the digestive system,Other functional intestinal disorders,18039,1619,1.03 [0.93-1.15],0.576703504972252
AGER,Advanced glycosylation end product-specific receptor,Chapter XI Diseases of the digestive system,Other gastritis (incl. Duodenitis),19630,1867,1.29 [1.17-1.43],3.486468811991662e-07
AGER,Advanced glycosylation end product-specific receptor,Chapter XI Diseases of the digestive system,Other inflammatory liver diseases,22748,97,1.06 [0.69-1.64],0.787014600762305
AGER,Advanced glycosylation end product-specific receptor,Chapter XI Diseases of the digestive system,Other noninfective gastroenteritis and colitis,22953,771,1.27 [1.09-1.48],0.0019937302102834
AGER,Advanced glycosylation end product-specific receptor,Chapter XI Diseases of the digestive system,"Other or unspecified ileus, impaction or obstruction",16772,352,1.02 [0.81-1.28],0.8684635587620284
AGER,Advanced glycosylation end product-specific receptor,Chapter XI Diseases of the digestive system,Palatinal maxillary canine,23578,55,1.17 [0.65-2.10],0.5950070344633969
AGER,Advanced glycosylation end product-specific receptor,Chapter XI Diseases of the digestive system,Paralytic ileus and intestinal obstruction,16895,475,0.97 [0.80-1.18],0.7690155274201651
AGER,Advanced glycosylation end product-specific receptor,Chapter XI Diseases of the digestive system,"Postprocedural disorders of digestive system, not elsewhere classified",22101,163,1.18 [0.84-1.66],0.3295473545471483
AGER,Advanced glycosylation end product-specific receptor,Chapter XI Diseases of the digestive system,Recurring oral aphthae,23649,44,1.46 [0.78-2.74],0.241629942840652
AGER,Advanced glycosylation end product-specific receptor,Chapter XI Diseases of the digestive system,Stomatitis and related lesions,22800,106,1.14 [0.75-1.74],0.5387551373909797
AGER,Advanced glycosylation end product-specific receptor,Chapter XI Diseases of the digestive system,Toxic colitis,22228,46,1.54 [0.84-2.83],0.1654832572510599
AGER,Advanced glycosylation end product-specific receptor,Chapter XI Diseases of the digestive system,Ulcer of oesophagus,18063,300,1.02 [0.80-1.31],0.8564785703105708
AGER,Advanced glycosylation end product-specific receptor,Chapter XI Diseases of the digestive system,Ulcerative colitis,22328,146,1.35 [0.95-1.92],0.0950021500495452
AGER,Advanced glycosylation end product-specific receptor,Chapter XI Diseases of the digestive system,"Ulcerative colitis, NAS",22304,122,1.20 [0.81-1.78],0.3587218728948727
AGER,Advanced glycosylation end product-specific receptor,Chapter XI Diseases of the digestive system,Umbilical hernia,18465,362,0.75 [0.59-0.94],0.0132899451278206
AGER,Advanced glycosylation end product-specific receptor,Chapter XI Diseases of the digestive system,Vascular disorders of the intestines,16578,158,1.14 [0.81-1.61],0.4363687958770527
AGER,Advanced glycosylation end product-specific receptor,Chapter XI Diseases of the digestive system,Ventral hernia,18361,258,0.86 [0.66-1.13],0.2831603895729785
AGER,Advanced glycosylation end product-specific receptor,Chapter XI Diseases of the digestive system,Volvulus,16494,74,1.20 [0.73-1.98],0.4689961530974307
AGER,Advanced glycosylation end product-specific receptor,Chapter XII Diseases of the skin and subcutaneous tissue,Actinic keratosis,23586,329,1.30 [1.02-1.64],0.0304684454102497
AGER,Advanced glycosylation end product-specific receptor,Chapter XII Diseases of the skin and subcutaneous tissue,Arthropathic psoriasis,23350,68,1.29 [0.77-2.15],0.3377479847534428
AGER,Advanced glycosylation end product-specific receptor,Chapter XII Diseases of the skin and subcutaneous tissue,Atrophic disorders of skin,21674,97,0.95 [0.61-1.48],0.8056060452931512
AGER,Advanced glycosylation end product-specific receptor,Chapter XII Diseases of the skin and subcutaneous tissue,Cellulitis,22935,764,1.06 [0.91-1.24],0.428642695398022
AGER,Advanced glycosylation end product-specific receptor,Chapter XII Diseases of the skin and subcutaneous tissue,"Cutaneous abscess, furuncle and carbuncle",22367,196,1.21 [0.89-1.64],0.2306638479420573
AGER,Advanced glycosylation end product-specific receptor,Chapter XII Diseases of the skin and subcutaneous tissue,Decubitus ulcer and pressure area,22042,465,1.29 [1.06-1.56],0.0112977922081684
AGER,Advanced glycosylation end product-specific receptor,Chapter XII Diseases of the skin and subcutaneous tissue,Dermatitis,23370,269,1.05 [0.81-1.36],0.7296060826808123
AGER,Advanced glycosylation end product-specific receptor,Chapter XII Diseases of the skin and subcutaneous tissue,Dermatitis and eczema,23573,472,1.17 [0.97-1.43],0.107329953844884
AGER,Advanced glycosylation end product-specific receptor,Chapter XII Diseases of the skin and subcutaneous tissue,Dermatitis due to substances taken internally,23144,43,0.91 [0.46-1.77],0.77213988953215
AGER,Advanced glycosylation end product-specific receptor,Chapter XII Diseases of the skin and subcutaneous tissue,Diseases of the skin and subcutaneous tissue,22184,3170,1.10 [1.02-1.19],0.0110049823576726
AGER,Advanced glycosylation end product-specific receptor,Chapter XII Diseases of the skin and subcutaneous tissue,Disorders of skin appendages,23219,404,1.02 [0.82-1.26],0.8652164078810172
AGER,Advanced glycosylation end product-specific receptor,Chapter XII Diseases of the skin and subcutaneous tissue,Follicular cysts of skin and subcutaneous tissue,23110,295,1.01 [0.79-1.30],0.9123500585529876
AGER,Advanced glycosylation end product-specific receptor,Chapter XII Diseases of the skin and subcutaneous tissue,Infections of the skin and subcutaneous tissue,23206,1035,1.12 [0.98-1.28],0.1011517300001628
AGER,Advanced glycosylation end product-specific receptor,Chapter XII Diseases of the skin and subcutaneous tissue,"Lichen planus, including avohilmo",23652,28,0.49 [0.21-1.12],0.0889919305560031
AGER,Advanced glycosylation end product-specific receptor,Chapter XII Diseases of the skin and subcutaneous tissue,Lupus erythematosus,21600,23,1.23 [0.50-3.03],0.6500106317016257
AGER,Advanced glycosylation end product-specific receptor,Chapter XII Diseases of the skin and subcutaneous tissue,Nail disorders,22871,56,1.38 [0.80-2.39],0.2523035485112728
AGER,Advanced glycosylation end product-specific receptor,Chapter XII Diseases of the skin and subcutaneous tissue,Other and unspecified dermatitis,23365,264,1.01 [0.77-1.31],0.9605646986901704
AGER,Advanced glycosylation end product-specific receptor,Chapter XII Diseases of the skin and subcutaneous tissue,Other and unspecified disorders of skin and subcutaneous tissue,22053,476,0.97 [0.79-1.18],0.7444949438588333
AGER,Advanced glycosylation end product-specific receptor,Chapter XII Diseases of the skin and subcutaneous tissue,Other and unspecified epidermal thickening,21657,80,1.50 [0.94-2.41],0.0907955835825484
AGER,Advanced glycosylation end product-specific receptor,Chapter XII Diseases of the skin and subcutaneous tissue,Other and unspecified erythematous conditions,23596,81,1.63 [1.03-2.59],0.0363458325527716
AGER,Advanced glycosylation end product-specific receptor,Chapter XII Diseases of the skin and subcutaneous tissue,Other and unspecified local infections of skin and subcutaneous tissue,22390,219,1.41 [1.06-1.88],0.0167401030153302
AGER,Advanced glycosylation end product-specific receptor,Chapter XII Diseases of the skin and subcutaneous tissue,Other and unspecified psoriasis,23496,214,0.81 [0.60-1.09],0.1612727513411936
AGER,Advanced glycosylation end product-specific receptor,Chapter XII Diseases of the skin and subcutaneous tissue,Other contact dermatitis,23173,72,2.16 [1.35-3.45],0.001356377886257
AGER,Advanced glycosylation end product-specific receptor,Chapter XII Diseases of the skin and subcutaneous tissue,Other disorders of pigmentation,21644,67,1.43 [0.84-2.41],0.1844919819669713
AGER,Advanced glycosylation end product-specific receptor,Chapter XII Diseases of the skin and subcutaneous tissue,Other disorders of skin and subcutaneous tissue,23204,1627,1.17 [1.05-1.30],0.0041145703043863
AGER,Advanced glycosylation end product-specific receptor,Chapter XII Diseases of the skin and subcutaneous tissue,"Other disorders of skin and subcutaneous tissue, not elsewhere classified",22093,516,0.98 [0.81-1.19],0.8572512455806066
AGER,Advanced glycosylation end product-specific receptor,Chapter XII Diseases of the skin and subcutaneous tissue,Other epidermal thickening,21660,83,1.44 [0.91-2.30],0.1221081521412128
AGER,Advanced glycosylation end product-specific receptor,Chapter XII Diseases of the skin and subcutaneous tissue,Papulosquamous disorders,23573,291,0.84 [0.65-1.08],0.1677244400446126
AGER,Advanced glycosylation end product-specific receptor,Chapter XII Diseases of the skin and subcutaneous tissue,Pruritus,23155,54,1.33 [0.75-2.35],0.3250670006373769
AGER,Advanced glycosylation end product-specific receptor,Chapter XII Diseases of the skin and subcutaneous tissue,Psoriasis,23539,257,0.86 [0.66-1.13],0.2907600918748484
AGER,Advanced glycosylation end product-specific receptor,Chapter XII Diseases of the skin and subcutaneous tissue,Radiation-related disorders of the skin and subcutaneous tissue,23606,349,1.26 [1.00-1.58],0.0488005383354833
AGER,Advanced glycosylation end product-specific receptor,Chapter XII Diseases of the skin and subcutaneous tissue,Scar conditions and fibrosis of skin,21667,90,0.90 [0.57-1.44],0.6662628987553425
AGER,Advanced glycosylation end product-specific receptor,Chapter XII Diseases of the skin and subcutaneous tissue,Seborrhoeic keratosis,21848,271,0.90 [0.69-1.17],0.433853103292465
AGER,Advanced glycosylation end product-specific receptor,Chapter XII Diseases of the skin and subcutaneous tissue,Skin changes due to chronic exposure to nonionizing radiation,23599,342,1.29 [1.02-1.62],0.0308911448902558
AGER,Advanced glycosylation end product-specific receptor,Chapter XII Diseases of the skin and subcutaneous tissue,"Ulcer of lower limb, not elsewhere classified",21845,268,1.53 [1.19-1.98],0.0009144033272897
AGER,Advanced glycosylation end product-specific receptor,Chapter XII Diseases of the skin and subcutaneous tissue,Urticaria and erythema,23638,123,1.82 [1.26-2.63],0.0015152313070046
AGER,Advanced glycosylation end product-specific receptor,Chapter XIII Diseases of the musculoskeletal system and connective tissue,Adhesive capsulitis of shoulder,20437,90,1.19 [0.76-1.86],0.4405403469632218
AGER,Advanced glycosylation end product-specific receptor,Chapter XIII Diseases of the musculoskeletal system and connective tissue,Arthropathies,21592,4752,1.02 [0.96-1.09],0.5587423526611284
AGER,Advanced glycosylation end product-specific receptor,Chapter XIII Diseases of the musculoskeletal system and connective tissue,Arthrosis,20185,3345,0.97 [0.90-1.05],0.4337827073423482
AGER,Advanced glycosylation end product-specific receptor,Chapter XIII Diseases of the musculoskeletal system and connective tissue,Bursitis of shoulder,20418,71,0.89 [0.53-1.49],0.6578495656849956
AGER,Advanced glycosylation end product-specific receptor,Chapter XIII Diseases of the musculoskeletal system and connective tissue,Cervical disc disorders,20781,150,1.38 [0.98-1.96],0.0658396752745669
AGER,Advanced glycosylation end product-specific receptor,Chapter XIII Diseases of the musculoskeletal system and connective tissue,Cervicalgia,20773,142,1.58 [1.12-2.23],0.0099158460187846
AGER,Advanced glycosylation end product-specific receptor,Chapter XIII Diseases of the musculoskeletal system and connective tissue,Chondropathies,23461,68,1.20 [0.72-2.01],0.4824740978739896
AGER,Advanced glycosylation end product-specific receptor,Chapter XIII Diseases of the musculoskeletal system and connective tissue,"Collapsed vertebra, not elsewhere classified",20711,80,0.93 [0.58-1.50],0.7657490654271295
AGER,Advanced glycosylation end product-specific receptor,Chapter XIII Diseases of the musculoskeletal system and connective tissue,Coxarthrosis,17700,860,0.99 [0.85-1.15],0.8787268124359443
AGER,Advanced glycosylation end product-specific receptor,Chapter XIII Diseases of the musculoskeletal system and connective tissue,"Coxarthrosis, primary",23544,147,0.99 [0.69-1.41],0.9438928144177052
AGER,Advanced glycosylation end product-specific receptor,Chapter XIII Diseases of the musculoskeletal system and connective tissue,Deforming dorsopathies,20902,271,0.87 [0.67-1.13],0.3029070775854732
AGER,Advanced glycosylation end product-specific receptor,Chapter XIII Diseases of the musculoskeletal system and connective tissue,Diseases of the musculoskeletal system and connective tissue,20138,6222,1.00 [0.94-1.05],0.914515472658038
AGER,Advanced glycosylation end product-specific receptor,Chapter XIII Diseases of the musculoskeletal system and connective tissue,Disorders of continuity of bone,22601,90,1.03 [0.65-1.62],0.9132990020178076
AGER,Advanced glycosylation end product-specific receptor,Chapter XIII Diseases of the musculoskeletal system and connective tissue,Disorders of muscles,20513,166,1.21 [0.87-1.67],0.2638508483915037
AGER,Advanced glycosylation end product-specific receptor,Chapter XIII Diseases of the musculoskeletal system and connective tissue,Disorders of synovium and tendon,20773,426,1.09 [0.88-1.34],0.4211185112201242
AGER,Advanced glycosylation end product-specific receptor,Chapter XIII Diseases of the musculoskeletal system and connective tissue,Dorsopathies,22849,2218,1.04 [0.95-1.14],0.3999284676822765
AGER,Advanced glycosylation end product-specific receptor,Chapter XIII Diseases of the musculoskeletal system and connective tissue,Fibroblastic disorders,20710,363,0.94 [0.74-1.18],0.5697236560728649
AGER,Advanced glycosylation end product-specific receptor,Chapter XIII Diseases of the musculoskeletal system and connective tissue,Fibromyalgia,20401,54,1.50 [0.84-2.68],0.165959620219235
AGER,Advanced glycosylation end product-specific receptor,Chapter XIII Diseases of the musculoskeletal system and connective tissue,Ganglion,20439,92,1.00 [0.63-1.58],0.9954285107217224
AGER,Advanced glycosylation end product-specific receptor,Chapter XIII Diseases of the musculoskeletal system and connective tissue,Giant cell arteritis,23347,32,0.69 [0.32-1.49],0.34883314900914
AGER,Advanced glycosylation end product-specific receptor,Chapter XIII Diseases of the musculoskeletal system and connective tissue,Gonarthrosis,18295,1455,0.94 [0.84-1.06],0.3302561138272669
AGER,Advanced glycosylation end product-specific receptor,Chapter XIII Diseases of the musculoskeletal system and connective tissue,Gout,17823,983,1.28 [1.12-1.46],0.0003892134736458
AGER,Advanced glycosylation end product-specific receptor,Chapter XIII Diseases of the musculoskeletal system and connective tissue,"Gout, unspecified",23522,969,1.27 [1.11-1.45],0.0006732735062002
AGER,Advanced glycosylation end product-specific receptor,Chapter XIII Diseases of the musculoskeletal system and connective tissue,Hallux rigidus,16887,47,1.00 [0.52-1.90],0.9947853266336651
AGER,Advanced glycosylation end product-specific receptor,Chapter XIII Diseases of the musculoskeletal system and connective tissue,Hallux valgus (acquired),16920,80,0.91 [0.56-1.48],0.7001103125460744
AGER,Advanced glycosylation end product-specific receptor,Chapter XIII Diseases of the musculoskeletal system and connective tissue,Impingement syndrome of shoulder,20616,269,1.05 [0.80-1.37],0.7231040923569974
AGER,Advanced glycosylation end product-specific receptor,Chapter XIII Diseases of the musculoskeletal system and connective tissue,Internal derangement of knee,17462,622,1.11 [0.93-1.32],0.2435597745107144
AGER,Advanced glycosylation end product-specific receptor,Chapter XIII Diseases of the musculoskeletal system and connective tissue,Kyphosis,20674,43,0.96 [0.50-1.86],0.9102872834124586
AGER,Advanced glycosylation end product-specific receptor,Chapter XIII Diseases of the musculoskeletal system and connective tissue,Low back pain,21160,529,1.16 [0.97-1.40],0.1063929582736671
AGER,Advanced glycosylation end product-specific receptor,Chapter XIII Diseases of the musculoskeletal system and connective tissue,Lumbar disc prolapse,20896,265,1.07 [0.82-1.39],0.621815996237973
AGER,Advanced glycosylation end product-specific receptor,Chapter XIII Diseases of the musculoskeletal system and connective tissue,Meniscus derangement,17420,580,1.11 [0.92-1.33],0.2760847870844451
AGER,Advanced glycosylation end product-specific receptor,Chapter XIII Diseases of the musculoskeletal system and connective tissue,Myalgia,20411,64,0.97 [0.57-1.67],0.9226263140850128
AGER,Advanced glycosylation end product-specific receptor,Chapter XIII Diseases of the musculoskeletal system and connective tissue,"Neuralgia and neuritis, unspecified",20401,54,1.56 [0.89-2.75],0.1194152201799494
AGER,Advanced glycosylation end product-specific receptor,Chapter XIII Diseases of the musculoskeletal system and connective tissue,Osteomyelitis,22603,92,0.94 [0.60-1.46],0.7712327545536825
AGER,Advanced glycosylation end product-specific receptor,Chapter XIII Diseases of the musculoskeletal system and connective tissue,Osteopathies and chondropathies,23374,863,0.99 [0.86-1.15],0.928266156176464
AGER,Advanced glycosylation end product-specific receptor,Chapter XIII Diseases of the musculoskeletal system and connective tissue,Osteoporosis,22917,406,1.00 [0.80-1.23],0.9638359947723386
AGER,Advanced glycosylation end product-specific receptor,Chapter XIII Diseases of the musculoskeletal system and connective tissue,"Other (seronegative) rheumatoid arthritis, wide",23578,286,1.01 [0.79-1.30],0.9317272265879968
AGER,Advanced glycosylation end product-specific receptor,Chapter XIII Diseases of the musculoskeletal system and connective tissue,Other arthrosis,18710,1870,0.99 [0.90-1.10],0.9004853149343951
AGER,Advanced glycosylation end product-specific receptor,Chapter XIII Diseases of the musculoskeletal system and connective tissue,Other articular cartilage disorders,16892,52,1.13 [0.61-2.09],0.7003069222705003
AGER,Advanced glycosylation end product-specific receptor,Chapter XIII Diseases of the musculoskeletal system and connective tissue,Other bursopathies,20428,81,1.00 [0.62-1.63],0.99597413933842
AGER,Advanced glycosylation end product-specific receptor,Chapter XIII Diseases of the musculoskeletal system and connective tissue,Other crystal arthropathies,16895,55,1.43 [0.80-2.57],0.2235437952550395
AGER,Advanced glycosylation end product-specific receptor,Chapter XIII Diseases of the musculoskeletal system and connective tissue,Other deformities of toe(s),16885,45,0.82 [0.42-1.58],0.5486262204901942
AGER,Advanced glycosylation end product-specific receptor,Chapter XIII Diseases of the musculoskeletal system and connective tissue,Other disorders of bone,22696,185,1.18 [0.86-1.62],0.297139449871973
AGER,Advanced glycosylation end product-specific receptor,Chapter XIII Diseases of the musculoskeletal system and connective tissue,Other disorders of bone density and structure,22673,162,1.18 [0.84-1.65],0.3343276530462154
AGER,Advanced glycosylation end product-specific receptor,Chapter XIII Diseases of the musculoskeletal system and connective tissue,Other disorders of the musculoskeletal system and connective tissue,23627,84,1.73 [1.10-2.70],0.0166450201612253
AGER,Advanced glycosylation end product-specific receptor,Chapter XIII Diseases of the musculoskeletal system and connective tissue,"Other dorsopathies, not elsewhere classified",22144,1513,1.10 [0.99-1.23],0.0851654872651501
AGER,Advanced glycosylation end product-specific receptor,Chapter XIII Diseases of the musculoskeletal system and connective tissue,Other enthesopathies,20413,66,1.25 [0.74-2.12],0.4067490774033175
AGER,Advanced glycosylation end product-specific receptor,Chapter XIII Diseases of the musculoskeletal system and connective tissue,Other hammer toe(s) (acquired),16881,41,0.75 [0.37-1.51],0.4192632326073101
AGER,Advanced glycosylation end product-specific receptor,Chapter XIII Diseases of the musculoskeletal system and connective tissue,Other intervertebral disc disorders,21244,613,1.10 [0.93-1.31],0.2814908918795647
AGER,Advanced glycosylation end product-specific receptor,Chapter XIII Diseases of the musculoskeletal system and connective tissue,Other joint disorders,18540,1700,1.10 [0.99-1.23],0.0683400509385542
AGER,Advanced glycosylation end product-specific receptor,Chapter XIII Diseases of the musculoskeletal system and connective tissue,Other necrotizing vasculopathies,23372,57,0.95 [0.54-1.68],0.8560254499437053
AGER,Advanced glycosylation end product-specific receptor,Chapter XIII Diseases of the musculoskeletal system and connective tissue,Other psoriatic arthropathies,23644,63,1.29 [0.76-2.19],0.3494038290462143
AGER,Advanced glycosylation end product-specific receptor,Chapter XIII Diseases of the musculoskeletal system and connective tissue,Other shoulder lesions,20427,80,0.70 [0.43-1.14],0.1513949624162115
AGER,Advanced glycosylation end product-specific receptor,Chapter XIII Diseases of the musculoskeletal system and connective tissue,"Other soft tissue disorders, not elsewhere classified",21324,977,1.20 [1.05-1.38],0.0073682227584086
AGER,Advanced glycosylation end product-specific receptor,Chapter XIII Diseases of the musculoskeletal system and connective tissue,Other specified disorders of muscle,20442,95,1.42 [0.92-2.19],0.10957464423947
AGER,Advanced glycosylation end product-specific receptor,Chapter XIII Diseases of the musculoskeletal system and connective tissue,Other specified/unspecified arthritis,18038,1198,1.12 [0.99-1.27],0.0655007918454113
AGER,Advanced glycosylation end product-specific receptor,Chapter XIII Diseases of the musculoskeletal system and connective tissue,Other specified/unspecified disorders of  bone/cartilage,22595,84,1.21 [0.76-1.93],0.4231152116443726
AGER,Advanced glycosylation end product-specific receptor,Chapter XIII Diseases of the musculoskeletal system and connective tissue,Other specified/unspecified disorders of synovium and tendon +Other specified/unspecified bursopathies,20392,45,1.49 [0.78-2.83],0.2286907787104731
AGER,Advanced glycosylation end product-specific receptor,Chapter XIII Diseases of the musculoskeletal system and connective tissue,Other specified/unspecified inflammatory spondylopathies,20739,108,1.43 [0.96-2.13],0.0767310234219526
AGER,Advanced glycosylation end product-specific receptor,Chapter XIII Diseases of the musculoskeletal system and connective tissue,Other specified/unspecified soft tissue disorders,20847,500,1.18 [0.97-1.42],0.0977977454185761
AGER,Advanced glycosylation end product-specific receptor,Chapter XIII Diseases of the musculoskeletal system and connective tissue,Other systemic involvement of connective tissue,23506,191,0.69 [0.50-0.95],0.0230726354325281
AGER,Advanced glycosylation end product-specific receptor,Chapter XIII Diseases of the musculoskeletal system and connective tissue,Other/unspecified dorsalgia,21105,474,1.12 [0.92-1.36],0.2622078755587874
AGER,Advanced glycosylation end product-specific receptor,Chapter XIII Diseases of the musculoskeletal system and connective tissue,Other/unspecified rheumatoid arthritis,23587,280,0.93 [0.72-1.20],0.5857909425389389
AGER,Advanced glycosylation end product-specific receptor,Chapter XIII Diseases of the musculoskeletal system and connective tissue,Other/unspecified seropositive rheumatoid arthritis,23647,38,1.14 [0.57-2.26],0.7088963885051975
AGER,Advanced glycosylation end product-specific receptor,Chapter XIII Diseases of the musculoskeletal system and connective tissue,Other/unspecified synovitis and tenosynovitis,20495,148,1.12 [0.79-1.60],0.5216309782650133
AGER,Advanced glycosylation end product-specific receptor,Chapter XIII Diseases of the musculoskeletal system and connective tissue,Pain in joint,19404,571,1.15 [0.97-1.38],0.1137394511531661
AGER,Advanced glycosylation end product-specific receptor,Chapter XIII Diseases of the musculoskeletal system and connective tissue,Pain in limb,20827,480,1.39 [1.15-1.69],0.0006642496253441
AGER,Advanced glycosylation end product-specific receptor,Chapter XIII Diseases of the musculoskeletal system and connective tissue,Palmar fascial fibromatosis [Dupuytren],20676,329,0.90 [0.71-1.15],0.4064905083177904
AGER,Advanced glycosylation end product-specific receptor,Chapter XIII Diseases of the musculoskeletal system and connective tissue,"Polyarthritis, unspecified",16870,30,1.85 [0.85-3.99],0.1187488431272461
AGER,Advanced glycosylation end product-specific receptor,Chapter XIII Diseases of the musculoskeletal system and connective tissue,Polyarthropathies,19100,2260,1.14 [1.04-1.25],0.0051966641509525
AGER,Advanced glycosylation end product-specific receptor,Chapter XIII Diseases of the musculoskeletal system and connective tissue,Polyarthrosis,17289,449,1.05 [0.85-1.29],0.6603284866221252
AGER,Advanced glycosylation end product-specific receptor,Chapter XIII Diseases of the musculoskeletal system and connective tissue,Polymyalgia rheumatica,23476,161,0.59 [0.42-0.84],0.003309138242338
AGER,Advanced glycosylation end product-specific receptor,Chapter XIII Diseases of the musculoskeletal system and connective tissue,"Postprocedural musculoskeletal disorders, not elsewhere classified",23589,46,2.43 [1.40-4.23],0.0015729926290635
AGER,Advanced glycosylation end product-specific receptor,Chapter XIII Diseases of the musculoskeletal system and connective tissue,"Primary gonarthrosis, bilateral",21685,44,1.26 [0.68-2.34],0.4591668703949196
AGER,Advanced glycosylation end product-specific receptor,Chapter XIII Diseases of the musculoskeletal system and connective tissue,Psoriatic arthropathies,16905,65,1.31 [0.76-2.25],0.3268875072435858
AGER,Advanced glycosylation end product-specific receptor,Chapter XIII Diseases of the musculoskeletal system and connective tissue,Radiculopathy,20718,87,0.78 [0.49-1.24],0.2895418603940581
AGER,Advanced glycosylation end product-specific receptor,Chapter XIII Diseases of the musculoskeletal system and connective tissue,Rheumatoid arthritis,17134,294,1.05 [0.81-1.35],0.7222509408983822
AGER,Advanced glycosylation end product-specific receptor,Chapter XIII Diseases of the musculoskeletal system and connective tissue,Rotator cuff syndrome,20624,277,1.09 [0.84-1.41],0.5351411180797827
AGER,Advanced glycosylation end product-specific receptor,Chapter XIII Diseases of the musculoskeletal system and connective tissue,Sciatica+with lumbago,20845,214,0.87 [0.64-1.16],0.334773175243964
AGER,Advanced glycosylation end product-specific receptor,Chapter XIII Diseases of the musculoskeletal system and connective tissue,Scoliosis,20724,93,1.00 [0.64-1.56],0.9845910413334916
AGER,Advanced glycosylation end product-specific receptor,Chapter XIII Diseases of the musculoskeletal system and connective tissue,Seronegative rheumatoid arthritis,18784,31,0.71 [0.32-1.57],0.4039805779950364
AGER,Advanced glycosylation end product-specific receptor,Chapter XIII Diseases of the musculoskeletal system and connective tissue,"Seropositive rheumatoid arthritis, wide",23648,39,1.20 [0.61-2.35],0.595205865412999
AGER,Advanced glycosylation end product-specific receptor,Chapter XIII Diseases of the musculoskeletal system and connective tissue,Shoulder lesions,20871,524,1.06 [0.88-1.28],0.5284084444793152
AGER,Advanced glycosylation end product-specific receptor,Chapter XIII Diseases of the musculoskeletal system and connective tissue,Sicca syndrome [Sj¬ögren],23335,20,1.38 [0.56-3.44],0.4842555671390748
AGER,Advanced glycosylation end product-specific receptor,Chapter XIII Diseases of the musculoskeletal system and connective tissue,Soft tissue disorders,22595,2248,1.11 [1.01-1.22],0.0233392259007567
AGER,Advanced glycosylation end product-specific receptor,Chapter XIII Diseases of the musculoskeletal system and connective tissue,"Soft tissue disorders related to use, overuse and pressure",20453,106,0.83 [0.54-1.28],0.4052361108127871
AGER,Advanced glycosylation end product-specific receptor,Chapter XIII Diseases of the musculoskeletal system and connective tissue,Spinal stenosis,21136,505,1.03 [0.85-1.25],0.7501972055217881
AGER,Advanced glycosylation end product-specific receptor,Chapter XIII Diseases of the musculoskeletal system and connective tissue,Spondyloarthritis,22600,195,1.34 [0.99-1.82],0.0546360328670665
AGER,Advanced glycosylation end product-specific receptor,Chapter XIII Diseases of the musculoskeletal system and connective tissue,Spondylolisthesis/Spondylolysis,20759,128,0.87 [0.59-1.27],0.4588221927914263
AGER,Advanced glycosylation end product-specific receptor,Chapter XIII Diseases of the musculoskeletal system and connective tissue,Spondylopathies,21938,1307,1.13 [1.01-1.27],0.0367532664333022
AGER,Advanced glycosylation end product-specific receptor,Chapter XIII Diseases of the musculoskeletal system and connective tissue,Spondylosis,21447,816,1.17 [1.01-1.35],0.0395374566635949
AGER,Advanced glycosylation end product-specific receptor,Chapter XIII Diseases of the musculoskeletal system and connective tissue,Synovial cyst of popliteal space [Baker],20388,41,0.88 [0.44-1.75],0.714167661744016
AGER,Advanced glycosylation end product-specific receptor,Chapter XIII Diseases of the musculoskeletal system and connective tissue,Systemic lupus erythematosus,23354,39,1.49 [0.76-2.92],0.2497506462324854
AGER,Advanced glycosylation end product-specific receptor,Chapter XIII Diseases of the musculoskeletal system and connective tissue,Trigger finger,20463,116,1.17 [0.78-1.73],0.446841136280063
AGER,Advanced glycosylation end product-specific receptor,Chapter XIII Diseases of the musculoskeletal system and connective tissue,Trochanteric bursitis,20370,23,0.62 [0.25-1.55],0.3106015151351876
AGER,Advanced glycosylation end product-specific receptor,Chapter XIII Diseases of the musculoskeletal system and connective tissue,Wrist or foot drop (acquired),16900,60,1.20 [0.68-2.10],0.5316928490302851
AGER,Advanced glycosylation end product-specific receptor,Chapter XIV Diseases of the genitourinary system,Acute renal failure,22653,1862,1.55 [1.41-1.71],1.0414222056291589e-18
AGER,Advanced glycosylation end product-specific receptor,Chapter XIV Diseases of the genitourinary system,Calculus of kidney and ureter,23188,402,1.12 [0.91-1.39],0.2935703824154837
AGER,Advanced glycosylation end product-specific receptor,Chapter XIV Diseases of the genitourinary system,Calculus of lower urinary tract,22921,135,0.81 [0.56-1.18],0.2726273981600701
AGER,Advanced glycosylation end product-specific receptor,Chapter XIV Diseases of the genitourinary system,Chronic kidney disease,22339,1548,2.66 [2.42-2.93],1.3492279179985663e-88
AGER,Advanced glycosylation end product-specific receptor,Chapter XIV Diseases of the genitourinary system,Chronic nephritic syndrome,23411,86,4.89 [3.74-6.40],3.6322396202603477e-31
AGER,Advanced glycosylation end product-specific receptor,Chapter XIV Diseases of the genitourinary system,Cyst of kidney,23380,360,1.34 [1.07-1.67],0.0104038431416025
AGER,Advanced glycosylation end product-specific receptor,Chapter XIV Diseases of the genitourinary system,Cystitis,20805,210,1.19 [0.88-1.60],0.2567816273784311
AGER,Advanced glycosylation end product-specific receptor,Chapter XIV Diseases of the genitourinary system,Dialysis,20896,105,7.48 [6.06-9.24],6.578893023940802e-78
AGER,Advanced glycosylation end product-specific receptor,Chapter XIV Diseases of the genitourinary system,Diseases of male genital organs,22385,3291,1.05 [0.97-1.13],0.2078719651193064
AGER,Advanced glycosylation end product-specific receptor,Chapter XIV Diseases of the genitourinary system,Genitourinary diseases,21303,5554,1.16 [1.09-1.23],1.2244601729977009e-06
AGER,Advanced glycosylation end product-specific receptor,Chapter XIV Diseases of the genitourinary system,Glomerular disorders in diseases classified elsewhere,23428,103,3.41 [2.51-4.62],2.572112241010648e-15
AGER,Advanced glycosylation end product-specific receptor,Chapter XIV Diseases of the genitourinary system,Hydrocele,19300,206,1.03 [0.76-1.38],0.8711907432568083
AGER,Advanced glycosylation end product-specific receptor,Chapter XIV Diseases of the genitourinary system,Hydronephrosis,20897,371,1.43 [1.14-1.79],0.0020322698179164
AGER,Advanced glycosylation end product-specific receptor,Chapter XIV Diseases of the genitourinary system,Hyperplasia of prostate,21688,2594,1.08 [0.99-1.18],0.0662058184284271
AGER,Advanced glycosylation end product-specific receptor,Chapter XIV Diseases of the genitourinary system,Inflammatory diseases of prostate (prostatitis),19324,230,1.02 [0.77-1.35],0.9033679935876848
AGER,Advanced glycosylation end product-specific receptor,Chapter XIV Diseases of the genitourinary system,Neuromuscular dysfunction of bladder,20673,78,2.14 [1.34-3.40],0.0013374475951631
AGER,Advanced glycosylation end product-specific receptor,Chapter XIV Diseases of the genitourinary system,Orchitis and epididymitis,19201,107,1.30 [0.87-1.95],0.2049171809636506
AGER,Advanced glycosylation end product-specific receptor,Chapter XIV Diseases of the genitourinary system,"Other chronic cystitis, drug-induced",23651,61,1.34 [0.78-2.29],0.2826091037583442
AGER,Advanced glycosylation end product-specific receptor,Chapter XIV Diseases of the genitourinary system,"Other cystitis, drug-induced",23655,58,1.05 [0.59-1.85],0.8715619267983024
AGER,Advanced glycosylation end product-specific receptor,Chapter XIV Diseases of the genitourinary system,Other diseases of urinary system,22831,2236,1.15 [1.05-1.26],0.0028070556784039
AGER,Advanced glycosylation end product-specific receptor,Chapter XIV Diseases of the genitourinary system,Other disorders of  bladder,21542,947,1.13 [0.98-1.30],0.0815224819017218
AGER,Advanced glycosylation end product-specific receptor,Chapter XIV Diseases of the genitourinary system,Other disorders of kidney and ureter,23586,566,1.67 [1.41-1.99],5.231756485899536e-09
AGER,Advanced glycosylation end product-specific receptor,Chapter XIV Diseases of the genitourinary system,Other disorders of male genital organs,19400,306,1.16 [0.91-1.49],0.2304652506618902
AGER,Advanced glycosylation end product-specific receptor,Chapter XIV Diseases of the genitourinary system,Other disorders of penis,19368,274,1.17 [0.90-1.51],0.2443225444599793
AGER,Advanced glycosylation end product-specific receptor,Chapter XIV Diseases of the genitourinary system,Other disorders of prostate,19323,229,1.06 [0.80-1.41],0.6759714647321289
AGER,Advanced glycosylation end product-specific receptor,Chapter XIV Diseases of the genitourinary system,Other disorders of the genitourinary system,23645,49,3.74 [2.41-5.83],4.987763056290227e-09
AGER,Advanced glycosylation end product-specific receptor,Chapter XIV Diseases of the genitourinary system,Other disorders of urethra and urinary system,22122,1527,1.22 [1.09-1.36],0.0003561817056729
AGER,Advanced glycosylation end product-specific receptor,Chapter XIV Diseases of the genitourinary system,Other obstructive and reflux uropathy,20943,417,1.58 [1.28-1.95],2.448612012322812e-05
AGER,Advanced glycosylation end product-specific receptor,Chapter XIV Diseases of the genitourinary system,Other specified disorders of kidney and ureter,23210,190,2.06 [1.55-2.75],8.447909788391746e-07
AGER,Advanced glycosylation end product-specific receptor,Chapter XIV Diseases of the genitourinary system,Recurrent and persistent haematuria,23384,59,1.82 [1.07-3.11],0.0278956346573449
AGER,Advanced glycosylation end product-specific receptor,Chapter XIV Diseases of the genitourinary system,"Redundant prepuce, phimosis and paraphimosis",19355,261,1.25 [0.96-1.62],0.1006850167053078
AGER,Advanced glycosylation end product-specific receptor,Chapter XIV Diseases of the genitourinary system,Renal tubulo-interstitial diseases,23360,2834,1.65 [1.52-1.78],7.862927086504638e-35
AGER,Advanced glycosylation end product-specific receptor,Chapter XIV Diseases of the genitourinary system,"Tubulo-interstitial nephritis, not specified as acute or chronic",20600,74,1.65 [1.00-2.71],0.0493159215121241
AGER,Advanced glycosylation end product-specific receptor,Chapter XIV Diseases of the genitourinary system,Unspecified kidney failure,20948,157,2.77 [2.05-3.75],3.3173558842027056e-11
AGER,Advanced glycosylation end product-specific receptor,Chapter XIV Diseases of the genitourinary system,Unspecified renal colic,22864,78,1.57 [0.98-2.50],0.0593639096429089
AGER,Advanced glycosylation end product-specific receptor,Chapter XIV Diseases of the genitourinary system,Urethral stricture,20887,292,1.35 [1.05-1.74],0.0172768084361376
AGER,Advanced glycosylation end product-specific receptor,Chapter XIV Diseases of the genitourinary system,Urolithiasis,23305,519,1.08 [0.89-1.30],0.4483575726286086
